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ABSTRACT OF DISSERTATION 
 
 
DATA MINING AND PATTERN DISCOVERY USING EXPLORATORY AND VISUALIZATION 
METHODS FOR LARGE MULTIDIMENSIONAL DATASETS 
 
Oral health problems have been a major public health concern profoundly affecting 
people’s general health and quality of life.  Given that oral health data is composed of 
several measurable dimensions including clinical measurements, socio-behavioral factors, 
genetic predispositions, self-reported assessments, and quality of life measures, strategies 
for analyzing multidimensional data are neither computationally straightforward nor 
efficient.  Researchers face major challenges to identify tools that circumvent the processes 
of manually probing the data.   
Moreover, studies have shown that many dental outcomes (such as tooth decays and 
gum diseases) are a function of multiple dimensions as well as the interplay between these 
dimensions.  Unfortunately, approaches to analyze multidimensional datasets are often 
over-simplified or isolated in components which fail to provide a comprehensive overview 
of the problem.  As a result, improvements in dental health and reduction in health burden 
cannot be achieved. 
The purpose of this dissertation is to provide applications of the proposed 
methodology on oral health-related data that go beyond identifying risk factors from a 
single dimension, and to describe large-scale datasets in a natural intuitive manner.  The 
three specific applications focus on the utilization of 1) classification regression tree (CART) 
to understand the multidimensional factors associated with untreated decay in childhood, 
2) network analyses and network plots to describe connectedness of concurrent co-morbid 
conditions for pediatric patients with autism receiving dental treatments under general 
anesthesia, and 3) random forests in addition to conventional adjusted main effects 
analyses to identify potential environmental risk factors and interactive effects for 
periodontitis. 
Compared to findings from the previous literature, the use of these innovative 
applications demonstrates overlapping findings as well as novel discoveries to the oral 
health knowledge.  The results of this research not only illustrate that these data mining 
techniques can be used to improve the delivery of information into knowledge, but also 
provide new avenues for future decision making and planning for oral health-care 
management.  
KEYWORDS:  Dental Caries, Parental Assessment, Periodontal Diseases, Autism Spectrum  
  Disorder, General Anesthesia  
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 Chapter One   
Introduction to Oral Health Problems 
Oral diseases have been a major public health concern profoundly affecting people’s 
general health and quality of life worldwide (Petersen et al., 2005).  The World Health 
Organization (WHO) has stated that “despite great improvements in the oral health status in 
oral health of populations in several countries, global problems still persist” (pg 661, 
Petersen et al., 2005).  Oral diseases and conditions such as dental caries, periodontal 
diseases, tooth loss, dental trauma, craniofacial anomalies, oral cancer, and HIV-related oral 
manifestations all have broad impacts on oral and general health.  Among these conditions, 
WHO recognizes dental caries and periodontal diseases as the most important global oral 
health burdens (World Health Organization, 2003).  A conceptual map describing the 
clinical measurements and characteristics of these two dominating diseases in different age 
population is shown in Figure 1-1.  Recent findings from surveillance data have raised 
awareness of these diseases and elevated them as a public health concern.  According to the 
National Health and Nutritional Survey (2009-2010), over half of Americans over the age of 
30 have periodontal diseases (Eke et al., 2012); Center of Disease Control Surveillance data 
revealed an increasing trend in dental caries in children aged 2 to 5 (Dye et al., 2007).   
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*Data used in this dissertation 
Figure 1-1. A conceptual map of clinical measurements and characteristics of periodontal 
diseases and dental caries 
 
While there have been improvements in oral health, these dental outcomes still 
disproportionally affect underprivileged groups (US Dept of Health and Human Service, 
2000; World Health Organization, 2003).  Individuals with limited access to dental services 
have the highest rates of oral diseases, and their ability to access oral health care is directly 
related to their socio-economic status (Dye et al., 2007; Centers for Disease Control and 
Prevention, 2009; Dye et al., 2007; US Dept of Health and Human Service, 2000).  To address 
this issue, one of the major objectives of Healthy People 2020 is to understand and 
overcome the barriers to preventive interventions and oral health care in order to reduce 
the disparity (Healthy People 2020).  
Biomedical and epidemiological studies have demonstrated well that the etiology 
and the pathological process of oral diseases involves interplay of multidimensional causal 
factors such as genetic, biological, socio-economical, behavioral, and health care utilization 
(Fisher-Owens  et al., 2007; P.E. Petersen et al., 2005).  For periodontitis, numerous studies 
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support the concept that the disease is multifactorial meaning the development of the 
disease involves more than one factor (Albandar and Rams, 2002; Meisel et al., 2003; Van 
Dyke and Dave, 2005).  To summarize, the framework for assessing multi-factorial risks to 
oral health is presented in Figure 1-2.  It is important for public health to consider the whole 
spectrum of causal chain as it is evident that the progression of disease might be 
complicated by a complex combination and interactions of genetic and environmental 
factors ranging from bacterial infections, genetic variations, behavioral factors and tobacco 
use (Brogden et al., 2002; Fredman et al., 2011).  
 
Figure 1-2. Risk factors associated with oral health outcomes. The risk factors outlined 
inside the large box are those that can be prevented through effective preventive strategies 
and health promotions. 
 
Oral health data has several important and measurable dimensions including 
clinical outcomes, self-reported assessments, demographic factors, health service uses, and 
quality of life.  Studies have demonstrated that many dental outcomes (such as tooth decays 
and gum diseases) are a result of the interactions of some or all of these dimensions (Chen 
and Clark, 2011; Litt et al., 1995; National Institutes of Health, 2003; Petersen et al., 2005).  
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However, multidimensional models have not been widely considered in oral health outcome 
research (Reisine and Litt, 1993).  In fact, much of the research in the literature either over-
simplifies or isolates the components of multidimensional models from each other such that 
the influence of multidimensional factors on oral health outcomes cannot be understood 
comprehensively (Gift et al., 1997).  Consequently, efforts in preventing oral diseases, 
improving dental health and reducing health burden and costs cannot be achieved (Gift et 
al., 1997). 
However, strategies for analyzing multidimensional data are neither 
computationally straightforward nor efficient.  In large-scale data with many variables, the 
traditional approach becomes inefficient and biased due to the subjectivity of the prior 
assumptions on the algorithmic procedures (Wong and Wang, 2003).  Additional 
complexities with modern oral health data are that much of the oral health-related 
administrative data such as claims database, electronic medical records, and hospital 
service data are not primarily collected for the purpose of health research.  Thus, these 
massive amounts of information are typically not organized in a structure that is readily 
analyzable.  With the lack of analytical strategies, the massive amount of information 
remains difficult to assimilate. 
A challenge is to go beyond identifying risk factors from a single dimension and to 
describe large-scale datasets in a natural intuitive manner.  Over the past decades, there are 
several data mining techniques that are typically designed to deal with multidimensional 
data.  They include neural networks, principal component analysis, decision trees, cluster 
analysis, nearest neighbor methods, and data visualization.  These methods have been used 
popularly to summarize patterns and identify signals, for example, in high-throughput DNA-
sequencing data (Brunet et al., 2004; Eisen et al., 1998), dynamic activities of administrative 
data (Gourinchas et al., 2011; Lei and Zhang, 2010), and large high-dimensional datasets 
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(Cordeiro et al., 2011).  By mapping data to numeric forms and translating them into 
interpretable information, these machine learning methods allow users to obtain insight 
into the data, draw conclusions, and interact with the data directly, especially when little is 
known about the data.  
This work proposes innovative ways to explore and analyze oral health data, and 
informs potential researchers about methods that could be used to address the complexities 
described earlier.  First, to better understand the multidimensional factors associated with 
untreated decay, classification regression tree (CART) is used to identify low-income 
children with untreated dental caries necessiting a dental referral at an early age.  Second, 
to associate large scale environmental chemical factors with a dichotomous oral health 
outcome, a systematic algorithm is outlined and demonstrated.  A statistical significance 
technique is included to control false discovery rates. Additionally, a post-hoc tree-based 
methodology is used to identify complex interactive effects from various dimensions.  Third, 
to summarize predominant co-morbid conditions associated with hospital dental patients 
from the electronic medical records, network analyses and network maps are utilized as an 
aid to delineate the data and identify patterns.  
The purpose of this work emphasizes the application of the proposed analytical 
methodology on oral health-related data.  Nonetheless, these methods can be easily 
extended to a variety of health outcome research where the inherent nature of the data is 
multidimensional. 
 
 
 
 
 
 
Copyright © Hsin-Fang Li 2013 
6 
 
Chapter Two 
A Simple Tool for Identifying Children with Untreated Dental Caries: A Cross-Sectional 
Study of Low-Income Children 
Introduction 
Early childhood caries in United States affects approximately 30% of children aged 2 
to 5 (1999-2004 NHANES) (Dye et al., 2007).  Among them, 72% of decayed or filled 
surfaces remain untreated.  In particular, children receiving public health insurance are the 
most vulnerable group of having dental diseases among all children (Cosgrove, 2009).  
Results from nationally represented survey data showed that 1 in 3 children aged 2-18 with 
Medicaid had untreated tooth decay and 1 in 9 had at least three untreated dental tooth 
decays (NHANES 1999-2004).  The Institute of Medicine (IOM) has recognized untreated 
dental decay as one of the urgent issues and concluded that reducing the proportion of 
children with untreated dental decay as one of the major goals in Healthy People 2020.  To 
address and improve the oral health needs of children, the American Academy of Pediatrics 
(AAP) and the American Academy of Pediatric Dentistry (AAPD) has developed risk 
assessment for clinicians to determine pediatric patients’ risk profile as the first step in 
caries management by risk assessment (CAMBRA)  (American Academy of Pediatric 
Dentistry, 2012).  The practice of CAMBRA method focuses on providing individualized care 
and recommendations by assessing multiple contributory factors with minimal invasive 
procedures.  Due to the multi-factorial nature of the disease, the assessment is developed to 
evaluate many predisposing risk factors including patient’s biological, socio-behavioral and 
lifestyle risk factors that contribute to the development or progression of dental decays at 
early stage life.  
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A significant social determinant of ECC is socio-economic status, with children from 
low-income households bearing a disproportionate burden of dental disease (Edelstein and 
Chinn, 2009a).  A child is at increased risk of ECC if the primary caregiver has experienced 
dental caries because the infectious bacteria are transmissible (Berkowitz, 2003; Tinanoff et 
al., 2002).  Both the AAPD and ADA risk assessment tools include social determinants of 
childhood caries such as “low socio-economic status” and “caries experience of the mother 
and/or siblings” (American Dental Association, 2008; Moore et al., 2010).  However, not 
every parent who has ever had a tooth restored or is economically disadvantaged will have 
a child predisposed to dental caries.  Jones and Tomar (2005) demonstrated that if the 
AAPD policy (American Academy of Pediatric Dentistry, 2012), which recommends all 
children receive an age one dental visit regardless of risk, was implemented, low risk, 
private pay patients could potentially crowd out at-risk, low-income children and ultimately 
increase the burden of dental disease in this population.  Hence, it becomes necessary to 
identify which of these children are truly at increased risk of developing ECC and require 
referral to a dentist beyond the socio-economical determinant. 
A tool should provide physicians with an accessible and efficient means of 
discerning the potential for untreated decay based on social determinants of the disease.  
Common statistical methods for pinpointing caries risk factors have been limited to 
descriptions by characteristics or regression involving averaged effects.  Due to the 
multifactorial nature of untreated decay, conventional methods are incomplete because 
they avoid potential interactive effects among the risk factors.  To detect interactions, 
multiple independent risk factors should be considered simultaneously.  Currently, no such 
standardized screening questions based on this approach exist.  Therefore, the aim of this 
study was to better understand the multidimensional factors associated with untreated 
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decay using regression trees (CART) to identify low-income children (aged from 0 to 5) with 
untreated dental caries necessitating a dental referral at an early age. 
Methods and Data Collection 
Study Subjects.  
This study is a secondary analysis of data (n =1322) collected over a three-year 
period (2004-2007), from a partnership between a regional Head Start program and the 
University of Kentucky, College of Dentistry, which provided comprehensive dental care to 
enrolled children.  Among the 1322 children, 381 were enrolled in the first year, 445 in the 
second year, and 496 in the third year.  Given the transitional nature of children in the Head 
Start study and that few differences were observed between programmatic years, all years 
were combined into one dataset for analysis; the first year of participation was used for 
children with multiple years of data (n=1322).  This study was approved by the University 
of Kentucky Human Subjects Medical Institutional Review Board (IRB).  Data were 
abstracted and stored in Microsoft Excel and imported into SAS v9.3 (SAS institute Inc, Cary, 
NC) for further management and data analysis. 
Dental Examination. Dentists used the Kentucky oral health surveillance method, utilizing a 
headlamp and mirror in the knee-to-knee position to examine the children.  The number of 
decayed, missing and filled teeth (dmft) present upon the initial dental examination was 
entered on a portable tablet that created electronic records. 
Survey instrument. Prior to the initial dental examination, parents/caregivers were given a 
questionnaire to complete.  The questionnaire included dental care history of the child 
(toothache in the past six months, length of time since last dental visit, reason for last dental 
visit, access to dental care in the past year) and demographics (child’s race, gender, age, 
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insurance type and parents’ education level).  Parents were also asked to evaluate the 
condition of their own teeth and their children’s teeth by providing responses to “Please 
describe the condition of your teeth?” and “Please describe the condition of your child’s 
teeth?”  Lastly, parents were asked if the child had a history of a serious chronic health 
condition or any serious health problems.  
Target outcome of interest. The outcome of interest is the number of decayed teeth (DT) in 
primary teeth.  Children in this study were classified as having had untreated caries 
experience if he/she had at least one tooth affected by untreated caries at the time of the 
initial dental examination.  
Statistical Analysis 
Categorical variables were described with counts and percentages, and continuous 
variables were summarized with descriptive statistics (n, mean, SD).  Descriptions were 
provided for untreated primary tooth decay; comparisons between groups were made using 
chi-square tests of independence.  Adjusted mean of DT were computed using analysis of 
covariance (ANCOVA) controlling for children’s age, gender, race, insurance type and 
parents’ education level.  
Classification and regression trees (CART) were used to identify variables involved 
with untreated decay.  CARTs are powerful and assumption-free alternatives to logistic 
regression and are often used to identify potential interactions (Nagy et al., 2010; Steadman 
et al., 2000; Vayssières et al., 2009).  The principal concept of CART is to select a series of 
splitting variables with the best splitting point that classify observations into groups with 
and without the target outcome.  The model starts by selecting the variable with the 
greatest association with the response.  Next, a splitting point associated with this variable 
is chosen among all possible splitting values that best classifies observations into groups of 
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high and low rates of outcome.  For each subgroup, another splitting variable and point are 
chosen to be evaluated.  This process branches out continuously to reveal potential 
interactions/effect modifiers (Refer to Hothorn 2006 for mathematical detail).  As a result, 
the selection process of this hierarchical modeling is summarized using a tree-like plot, and 
the combinations of factors can be easily visualized. 
After identifying classifying variables, sensitivity was computed as the proportion of 
patients with untreated decay who were correctly identified, while specificity was 
computed as the proportion of children without untreated decay who were correctly 
identified to be caries-free.  CART analysis was conducted using Rv2.15.1 with the party 
package (Hothorn et al., 2009; Hothorn et al., 2006) and all other analysis and data 
management was performed using SAS v9.3. 
Results 
The majority (67%) of children were between the ages of 3 and 4 years with 
Medicaid dental insurance (66%); the racial/ethnic composition of the sample was: black 
(44%), white (32%), Hispanic (21%) (Table 2-1).  Most (96%) indicated no significant 
health problems.  The overall prevalence of untreated tooth decay in primary teeth was 
34%, and the average number of DT for the entire group was 1.19 (SD=2.39).  
Untreated Primary Tooth Decay and Dental Care Experience.  
When compared to those without untreated decay, children with at least one 
decayed tooth were more likely to have experienced a toothache in the last 6 months (11% 
vs. 3%, p<0.0001), less likely to have visited a dentist within the past year (51% vs. 36%; 
p<.0001), more likely to have difficulty with dental care access (28% vs 15%, p<0.0001), 
and more likely to have parents who rated their own teeth as “fair/poor” (33% vs. 19%, 
11 
 
p<0.0001) and their child’s teeth as “fair/poor” (27% vs. 7%, p<0.0001).  Of those who 
visited the dentist (n =608), the primary reason for both groups of children was preventive 
care (81% overall).  Difficulties for accessing dental care were also similar between the two 
groups, with reasons such as “could not afford” (18%), “no way to get there” (11%), and 
“not serious enough” (9%).  For children with at least one decayed tooth, the mean number 
of decayed teeth was 3.5 (sd=2.9).  Prevalence of tooth decay in primary teeth and the 
number of DT increased with age and lower parent educational levels (Figures 2-1a and 2-
1b).  
Development of the untreated decay identification  tool 
The CART analysis explored which factor(s) were associated with untreated tooth 
decay in primary teeth.  Of the seven self-evaluated candidate factors in the model 
(children’s age, gender, race, insurance type, parents’ education level, parents’ assessment 
of their and their child’s teeth), three variables (children’s age, parents’ assessment of their 
own and their child’s teeth) were selected by CART as the splitting variables and potential 
effect modifiers to identify groups with the highest rates of tooth decay (75%, 56%, and 
48%).  Furthermore, CART analyses suggested that children in the sample under 2 did not 
demonstrate high rates of untreated tooth decay (Figure 2-2).  Among children who were 
older than 2 and whose parents assessed the children’s teeth and their own teeth as 
“fair/poor”, 75% had at least one decayed teeth.  In fact, regardless of the parents’ 
assessment of their own teeth, 67% of children had untreated tooth decay if their parents 
rated their teeth as “fair/poor”.  Additionally, among children who were older than 3, 48% 
were identified to have untreated decay(s) if the parents assessed their child’s teeth as 
“good/very good” but their own teeth as “good/fair/poor”.  Using children’s age and 
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parents’ assessment of their child’s teeth and their own teeth, the overall sensitivity and 
specificity were 43% and 78%, respectively. 
Further investigation of parents’ assessment of their own and their child’s teeth was 
conducted on children older than 2 years of age.  For children over 2, 85% of the children 
whose parents assessed both their own and their child’s teeth as “fair/poor” had untreated 
tooth decay; 64% of children whose parents indicated that both their own and their child’s 
teeth as “good/very good” did not have untreated tooth decay (Table 2-2).  Moreover, 
parents who rated their own teeth “good/very good” and their children’s teeth as 
“good/very good” had children with the lowest levels of untreated tooth decay, even after 
adjusting for children’s age, gender, race, insurance type, and parents’ education level 
([a]mean=0.8, SE=0.2); the adjusted mean DT was highest for children whose parents 
indicated that both their own and their child’s  teeth were “fair/poor” ([a]mean=4.1, 
SE=0.3).  Using the parents’ assessment of their child’s teeth and their own teeth for 
children older than 2 years of age yield an overall sensitivity and specificity were 43% and 
78%, respectively.  For children younger than age 2, 90% were correctly identified as being 
DT-free when parents responded “good/very good” to describe their own and their child’s 
teeth.  In contrast, 16% and 15% of children were correctly identified as having tooth decay 
if the parents indicated that either or both their own teeth and their child’s teeth were 
“fair/poor” and that their own teeth were “fair/poor”, respectively.  The adjusted mean DT 
was also significantly lower for children whose parents responded “good/very good” to 
both teeth assessment questions (p=0.0127) or “good/very good” to describe their own 
teeth, compared to all other responses (p=0.0027).  
Discussion 
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There is a growing consensus that pediatricians include an evaluation of a child’s 
dental/oral health.  The purpose of this study is to identify factors for identifying untreated 
decay in a high-risk population using classification and regression trees (CART) in order to 
assist pediatricians to make a decision early for children who need to see a dentist.  A low-
income population provides the opportunity to classify children’s risk beyond a low-income 
criterion.  The decision rules determined in the further investigation yield a high specificity 
(78%) and moderate sensitivity (43%), suggesting that for children over 2 years of age, two 
assessment questions directed at parents: 1) “Please describe the condition of your own 
teeth”; and 2) “Please describe the condition of your child’s teeth”, could be used as 
standard screening questions for untreated dental caries during a regular health care visit.  
The national prevalence rate of untreated dental decay is approximately 14% 
among children aged 3 to 5, and 25% among children living at or below 100% federal 
poverty level (NHANES 2009-2010).  Compared to the children living in poverty, the 
prevalence rate reported in this study is almost 1.5 times higher among children whose 
parents reported “good/very good” for their teeth and their child’s teeth, and nearly 3.5 
times higher among children whose parents reported “fair/poor” for both assessments.  Our 
findings reveal the high unmet oral health care for children in low-income families, 
especially those whose parents evaluated their own and their child’s teeth as fair or poor.  
In a multidimensional model developed by Fisher-Owen (Fisher-Owens et al., 2007), 
children’s oral health determinants are evolved from the traditional dental caries model to 
include community and family level influences over time.  The results of this study highlight 
and supported the importance of family-level factor for children older than 2. 
While some literature suggested that a useful screening tool should have a 
combined sensitivity and specificity of over 160% (Kingman et al., 1988; Stewart and 
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Stamm, 1991; Zero et al., 2001), few models have met the requirement.  For models that 
achieve such a standard, they typically involve clinical examinations and biological tests 
(Yoon et al., 2012) which are neither convenient nor necessary in a non-dental clinic setting.  
In fact, the goal of this analysis is to develop a tool based on parents’ self-report responses 
before performing any dental or clinical examinations.  Additionally, while many 
assessment tools are helpful to enumerate significant factors of dental decay, the measures 
of association to dental decay is often computed using regression equations (Gao et al., 2010) 
rather than specific guidelines that mimic the clinical reasoning.  In contrast, the guideline 
in this study provides a simple and easy-to-use decision making rules for dental referral and 
early treatment. 
Children’s age is a significant risk factor for dental decay as both the mean decayed 
teeth and the prevalence of primary tooth decay increases with children’s age (Figure 2-1a).  
In order to isolate the critical factors in identifying children with untreated dental decay, 
the sample was divided by age.  The results in Table 2-2 suggest that pediatricians should 
consider referring children older than 2 to a dentist if the parents did not respond 
“good/very good” to describe both their own teeth as well as their child’s teeth.  A response 
of “good/very good” to both of these standardized questions suggests the child is less likely 
to have untreated caries and requires only preventive dental care (oral hygiene instructions, 
dietary counseling and fluoride varnish application).  While factors related to the rate of 
untreated dental caries for children older than 2 were effectively identified by CART, it 
provided limited information for children under age 2.  For edentulous infants, a parent 
obviously cannot be asked to describe the condition of the child’s teeth.  Therefore, asking 
the parent “What is the condition of your teeth?” may be sufficient.  An answer of 
“fair/poor” would suggest that their child may be at increased risk of caries and should to 
be referred to a dentist for an age 1 visit.  
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Given that analyses are based on cross-sectional data, it remains unknown whether 
a caries-free child would be at greater risk for dental decay if the parental assessment of 
teeth was “fair/poor”.  Although this is a longitudinal evaluation, the transitional nature of 
the participants prevents adequate follow-up data (i.e. only 10% of children in the study 
had multiple years of data).  Ideally, the parents’ assessment of caries-free children could be 
used to identify children at risk, and follow-up data would indicate the effectiveness of the 
tool based on parental assessment of teeth.  There are indications from several longitudinal 
(Grytten et al., 1988; Shearer et al., 2011) and cross-sectional studies (Dye et al., 2011; 
Mannaa et al., 2013; Weintraub et al., 2010) that mother’s dental health has a significant 
effect on children’s oral health.  While dental caries involves interplay of biological, 
behavioral, socioeconomical, and demographic risk factors, the data is limited to provide 
important predictors such as parents/child risk behaviors and oral hygiene practices.  
Future data collection and investigation of these risk factors is merited.  
A potential limitation in the parents’ assessment of their child’s teeth was if they 
were aware of the results of any previous dental examinations.  Since parents may reiterate 
professional opinion, a stratified analysis was performed for children who had never visited 
a dentist.  Those with and without a history of dental visits had similar results, and higher 
rates of untreated tooth decay were observed in the “fair/poor” group.  
Young children from low-income families have a disproportionally high risk of 
dental caries compared to affluent children regardless of gender, race and ethnicity 
(Edeistein, 2000; Edelstein and Chinn, 2009b; US Department of Health and Human Services, 
2000).  One of the strengths of this study was that it was conducted in the Head Start 
population.  As a member of an economically disadvantaged family, every Head Start child is 
automatically considered to be at high risk for dental caries.  However, upon clinical 
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examination, only 34% of these children had untreated dental caries and the remaining 
66% were either treated or caries-free.  Using the existing ADA/AAPD caries risk 
assessment tools would have required that 100% of these Head Start children be referred 
by the pediatrician to a dentist for oral health care.  If the two proposed screening questions 
had been applied to this population, it would have resulted in decreasing the number of 
children in need of a referral to a dentist from 1322 to 465.  As caries identification 
sensitivity decreases, some of the high-risk children who should have been identified by the 
caries identification questions would not have been detected and potentially needed care 
may have been withheld (MacRitchie et al., 2012).  On the other hand, the high specificity of 
these potential screening questions decreases the likelihood of inappropriately classifying 
children as at risk, which decreases the burden on the health care system.  This point is 
important because dental referrals for poor children are problematic.  Dentists are reluctant 
to accept Medicaid patients and cite broken appointments, poor compliance and low 
reimbursement rates as reasons (Shulman et al., 2001; Venezie et al., 1997).  As a result, 
physicians face barriers to referral for children most in need of dental care (Cruz et al., 
2004).  Consequently, pediatricians may be hesitant to screen for dental caries if they are 
unable to refer the child for treatment.  Screening to reduce the number of Medicaid 
children needing to visit the dentist for treatment may ultimately increase the likelihood of 
these children obtaining dental appointments because: (1) a dentist may be more likely to 
accept a referral from a professional colleague that is valid, and (2) the patient has 
demonstrated a history of appointment keeping behavior with the physician. 
Conclusion 
Our findings demonstrate that the majority of economically disadvantaged children 
actually needing referral to a dentist for individualized professional rehabilitative care 
could be identified using these two standardized screening questions, despite being in a 
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high-risk group for early childhood caries because of their low socio-economic status.  The 
preventive dental needs of infants and toddlers identified as being at low risk for dental 
caries, despite being from a low-income family, could be met during their regular health 
supervision visits to the pediatrician (Haupt, 2004).  There is no need to fragment their care 
and refer them to a dentist for treatment. 
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Table 2-1. Demographic characteristics by decayed teeth experience 
  2004-2007* No Untreated Decay teeth Untreated 
Decayed 
teeth† 
 
P-
value 
Number of children 1322 868 454  
Children and Parents Characteristics 
Age Year     <.0001 
0 71 (5.4%) 71 (8.3%) 0 (0.0%)  
1 129 (9.9%) 123 (14.3%) 6 (1.3%)  
2 173 
(13.2%) 
140 (16.3%) 33 (7.3%)  
3 439 
(33.6%) 
270 (31.4%) 169 
(37.6%) 
 
4 433 
(33.1%) 
224 (26.1%) 209 
(46.5%) 
 
5 63 (4.8%) 31 (3.6%) 32 (7.1%)  
Gender    0.6803 
Female 683 
(51.7%) 
452 (52.1%) 231 
(50.9%) 
 
Male 639 
(48.3%) 
416 (47.9%) 223 
(49.1%) 
 
Racial Group    0.0030 
White 423 
(32.5%) 
303 (35.4%) 120 
(26.9%) 
 
Black 575 
(44.1%) 
376 (43.9%) 199 
(44.6%) 
 
Hispanic 274 
(21.0%) 
160 (18.7%) 114 
(25.6%) 
 
Other 31 (2.4%) 18 (2.1%) 13 (2.9%)  
Insurance    0.6255 
No insurance 166 
(13.6%) 
104 (12.9%) 62 
(14.9%) 
 
KCHIP 204 
(16.7%) 
138 (17.2%) 66 
(15.9%) 
 
Medicaid 806 
(66.1%) 
536 (66.7%) 270 
(65.1%) 
 
Other Insurance 43 (3.5%) 26 (3.2%) 17 (4.1%)  
Caretaker’s Education 
Level 
   <.0001 
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Table 2-1 (Continued) 
High School 453 
(42.1%) 
270 (37.6%) 183 
(51.4%) 
 
Some College 492 
(45.8%) 
361 (50.2%) 131 
(36.8%) 
 
College Graduate 130 
(12.1%) 
88 (12.2%) 42 
(11.8%) 
 
Caries and Dental Care Experience 
Toothache in six month 
No 
Yes 
 
1068 
(94.3%) 
 
726 
(97.3%) 
 
342 
(88.6%) 
<.0001 
64 (5.7%) 20 (2.7%) 44 
(11.4%) 
Last dental visit 
≤ 1 year 
> 1 year 
Never have been 
 
497 (41.3%) 
 
289 
(36.4%) 
 
208 
(50.6%) 
<.0001 
111 (9.2%) 61 (7.7%) 50 
(12.2%) 
596 (49.5%) 443 
(55.9%) 
153 
(37.2%) 
Main reason for dental visit a 
Check-up, exam, or cleaning 
Something was wrong, bothering 
or hurting 
Follow-up treatment 
Other 
 
 
500 (84.5%) 
 
34 (5.7%) 
 
31 (5.2%) 
27 (4.6%) 
 
 
208 
(78.5%) 
 
25 (9.4%) 
 
22 (8.3%) 
10 (3.8%) 
 
 
292 
(89.3%) 
 
9 (2.8%) 
 
9 (2.8%) 
17 (5.2%) 
<.0001 
Could not get dental care when 
needed 
No 
Yes 
   <.0001 
883 (80.3%) 612 
(84.6%) 
271 
(71.9%) 
217 (19.7%) 111 
(15.4%) 
106 
(28.1%) 
Parents’ assessment of their child’s 
teeth 
Fair/Poor 
Good 
Very Good 
   <.0001 
170 (14.2%) 57 (7.4%) 113 
(26.8%) 
520 (43.6%) 325 
(42.2%) 
195 
(46.2%) 
503 (42.2%) 389 
(50.5%) 
114 
(27.0%) 
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Note: The sample size for each survey item represents the number of participants who 
provided responses. 
†At least one tooth affected by untreated caries 
* For children enrolled in multiple years, the first year of enrollment is used (N=1322). 
a This is a followup question for those who have seen a dentist before. 
b Serious health conditions includes rheumatic disease/heart problems, cancer, hemophilia 
or bleeding problems, epilepsy, asthma, tuberculosis, allergies and any serious health 
problems. 
 
 
 
 
 
 
Table 2-1 (Continued)     
Parents’ assessment of their own 
teeth 
Fair/Poor 
Good 
Very Good 
   <.0001 
280 (23.5%) 145 
(18.5%) 
135 
(32.8%) 
639 (53.6%) 421 
(53.8%) 
218 
(53.0%) 
274 (23.0%) 216 
(27.6%) 
58 
(14.1%) 
Serious Health Conditionsb 
No 
Yes 
   0.8307 
1209 
(96.3%) 
790 
(96.3%) 
419 
(96.1%) 
47 (3.7%) 30 (3.7%) 17 (3.9%) 
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Figure 2-1a) Age-related prevalence of untreated decay teeth and mean decayed teeth 
 
 
 
Figure 2-1b) parents’ education-related prevalence of untreated decay teeth and mean 
decayed teeth 
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Figure 2-2. The results of the conditional inference tree model to identify children at risk of 
untreated decay teeth by a combination of the most significant variables.  
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Table 2-2. Caries Experience by  parents’ evaluation of their own and their children’s   teeth 
 
Parents evaluation 
own/child teeth 
 No 
Untreated 
Decayed 
Teeth 
Have 
Untreated 
Decayed 
Teeth 
# of 
Decayed 
teeth† 
# of 
Decayed 
Teethadj* 
P*val 
Parent Child N      
Age>2      <.0001 
Very 
good/Good 
Very 
good/Good 
575 365 
(63.5%) 
210 
(36.5%) 
1.02 
(0.08) 
0.79 
(0.16) 
 
Fair/Poor Very 
good/Good 
125 75 
(60.0%) 
50 
(40.0%) 
1.13 
(0.17) 
0.96 
(0.23) 
 
Very 
good/Good 
Fair/Poor 48 15 
(31.3%) 
33 
(68.7%) 
3.75 
(0.60) 
3.05 
(0.35) 
 
Fair/Poor Fair/Poor 85 13 
(15.3%) 
72 
(84.7%) 
4.66 
(0.43) 
4.10 
(0.28) 
 
†Number of decayed primary teeth described in mean (standard error). 
*The least square mean (standard error) is estimated and compared using ANCOVA 
adjusting for children’s age, race, gender, insurance type, and parents’ education level. P-
value is estimated from the corresponding ANCOVA model. 
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Chapter Three 
Visualizing the Co-Morbidity Burden in Children with Pediatric Autism and Impact on 
Access to Comprehensive Oral Health Care 
Introduction 
Autism is described as a neurological and developmental disorder involving social, 
behavioral, and communicative impairments and conditions (Jaber et al., 2011).  Since the 
1980’s, diagnoses of autism have risen dramatically; the prevalence of autism in children 
has climbed to 1 in 88 (1.13%) in the United States, but it is most likely that these increases 
are due to greater awareness and changing definitions of the disorder (Baio, 2012; Rice, 
2009; Rutter, 2005).  Characterizing autism in children is complicated and relies on the 
assessment of behaviors and development (US Department of Health and Human Services, 
2008).  Moreover, recent modifications to diagnostic criteria have resulted in defining 
autism spectrum disorder (ASD) which incorporates diagnoses of autism along with 
Asperger’s disorder and pervasive developmental disorder – not otherwise specified 
(Diagnostic and Statistical manual of mental disorders - V, 2013).  The American Psychiatric 
Association suggests using a two-domain model in the diagnosis of ASD.  The domains are 
represented by 1) socio-communication deficits, and 2) restricted interests/repetitive 
behaviors (DSM - V, 2013).  The onset of these symptoms usually occurs before the age of 3 
(Kopycka-Kedzierawski and Auinger, 2008), and the disorder is five times as common in 
boys as in girls (Baio, 2012).   
Beyond the issues associated with ASD, these children may face additional 
challenges when seeking comprehensive healthcare. Children with ASD also have multiple 
concurrent medical diagnoses (Charles, 2010; Grinstein, 2001; Kogan et al., 2008; Kohane et 
al., 2012; Rada, 2010) and may find that the conditions of clinics and that the process of 
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obtaining care exacerbate conditions associated with ASD.  For example, children with ASD 
are at most ease under the environment that is undistracting, sterile, and with soft 
furnishings; however, most pediatric dental offices are designed to be interactive, bright, 
and appealing to children.  Moreover, children with ASD present a unique challenge to 
dentists and oral healthcare professionals due to their limited ability to comprehend and 
communicate efficiently, interact normally, and follow directions (Chiri and Warfield, 2012; 
Lai et al., 2012).  Additionally, children affected by ASD may have unusual responses to 
sounds, lights, or touches which greatly intervene with the dental examination and 
complicates the treatment (Charles, 2010; Medina et al., 2003). 
Children with ASD are believed to have poorer oral health due to other possible 
concurrent medical diagnoses, effects of prescribed medications, poor dietary habits, and 
damaging oral habits (Jaber, 2011; Klein and Nowak, 1998; Kopycka-Kedzierawski and 
Auinger, 2008; Marshall et al., 2007; Saraiya et al., 2004).  However, it is not clear that these 
result in especially high rates of caries (Fahlvik-Planefeldt and Herrstrom, 2001; Loo et al., 
2008; Murshid, 2005; Shapira et al., 1989), but children with ASD have been shown to 
exhibit extensive unmet needs for dental treatments and restorative care when compared 
to healthy children (Chiri and Warfield, 2012; Jaber, 2011).  The American Academy of 
Pediatric Dentistry (AAPD) recommends that special dental procedures such as general 
anesthesia (GA) be considered for children with ASD (Ganem, 2011; Jaber, 2011), which 
may require dental treatment in a hospital setting.  Dental treatment under GA in a hospital 
setting is characterized by long waiting times and high healthcare costs associated with the 
procedure (Forsyth et al., 2012; Johnson et al., 2010; Kanellis et al., 2000; Lewis and Nowak, 
2002; North et al., 2007; Saraiya et al., 2004; White et al., 2008).  A retrospective analysis 
showed that the average cost of GA in hospital setting for ASA I pediatric patients aged 3-5 
years old was estimated to be $7,303 (Rashewsky et al., 2012).  Since not all dental 
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surgeries under general anesthesia may be recorded, it is unclear how many children 
underwent the treatment and the percentage of total cost of the treatment to the hospital 
GA system.  However, data based on the Medicaid program in Iowa showed that the GA fee 
for 2% of the Medicaid-eligible children aged 6 and less accounted for 25% of the total 
dental expenditure (Kanellis et al., 2000).  With the increasing trajectory of children 
diagnosed with ASD, it is important to understand and incorporate the patterns of 
development of the disease and the burden of concurrent health concerns these children 
face in the future planning of public health and healthcare access policies (Jaber et al., 
2011).  
Systematic desensitization is a type of behavioral therapy that can be used to help 
children with ASD cope with anxiety and receive oral health care in a conventional dental 
clinic setting (Lang et al., 2010; Moree and Davis, 2010).  However, for children severely 
impacted with multiple communicative, sensory and developmental disorders, utilization of 
such therapies may be ineffective (Marshall et al., 2008; Marshall et al., 2007).  Little is 
known about the penetrance of ASD in children receiving dental treatment under GA and 
their co-morbidity burden.  Understanding the co-morbidity burden helps clarify whether 
children with ASD receiving dental treatment under GA could possibly have benefited from 
alternative strategies that are less invasive and less costly and with less wait times (Chew et 
al., 2006).  Familiarizing the children with basic dental instruments and procedures at home 
prior to dental treatment (Chew et al., 2006), and performing treatments in slow and small 
steps (Charles, 2010) may be helpful to reduce the time in preparing children with autism 
for dental treatment.  When more aggressive behavioral management beyond 
desensitization is needed for dental surgery, office-based sedation can be performed as safe 
and time-efficient as GA in an OR for children with ASA I (Lalwani et al., 2007; Rashewsky et 
al., 2012).  
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The purpose of this paper is to describe the co-morbidity burden and characterize 
the complexity of the concurrent disorders and conditions of children with ASD receiving 
dental treatment under general anesthesia.  
Method 
A retrospective review was conducted on pediatric hospital patients receiving full 
mouth dental rehabilitation under general anesthesia from June 1st, 2009 to June 31st, 
2012.  Hospital paper charts and Xtract software were used to collect date of birth, sex, 
postal code, date of treatment, provider, payment method, American Society of 
Anesthesiologists (ASA) physical status, and medical diagnosis.  Medical diagnoses were 
categorized using the International Classification of Diseases (ICD) 10 codes.  The ICD-10 
coding system consists of 21-chapter guidelines each containing blocks of categories, 
categories and subcategories (individual diagnosis level) of disease classification.  Based on 
this coding system, childhood autism is classified into the chapter of “Mental and Behavioral 
Disorders”, blocks of “Disorders of Psychological Development”, and categories of 
“Pervasive Developmental Disorder".  Using ICD10 chapters, blocks, and categories, 
subcategories, and diagnoses levels, children with autism (F84.0) were identified (Figure 3-
1).  Children’s caries experience was described by using the number of decayed, missing and 
filled teeth of 1) the primary teeth (dmft), and 2) the permanent teeth (DMFT) for each 
child.  
Children included were those treated by hospital staff pediatric dentists and 
community pediatric dentists.  The eligibility criteria for treatment in the dental operating 
room were: 1) children who were 48 months old and under with severe caries, and 2) 
children older than 4 years of age with a significantly compromising medical 
condition/comorbidity in addition to dental caries who were referred to the hospital by 
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their dentists.  The study included children from all age groups (N=2352).  Eleven children 
were excluded from the data because their residence was outside of British Columbia.  
Among the remaining children (N=2341), those without dmft and DMFT data were 
excluded.  In the remaining data (N=1582), 97% were seen by hospital pediatric dentists. 
The final analytical dataset contained a total of 1582 children, and these children were 
grouped into those with an autism diagnosis (N=303) and those without (N=1279).  
Descriptive analyses were performed to describe the demographic and clinical 
variables.  Categorical variables were described with counts and percentages, and 
continuous variables were summarized with descriptive statistics (n, mean, SD).  Children 
were stratified by age groups: 1) under 6, 2) between 6 and 12, and 3) at least 12 years old 
and caries experience described.  Independent two-sample t tests and chi-square tests of 
independence were used to make comparisons of children with and without autism for 
continuous and categorical variables, respectively.   
To characterize the interconnectedness of concurrent health conditions, patterns of 
conditions were graphically displayed using network plots.  While network plots are 
traditionally used to describe connections between individuals, the novel use of network 
plots in the description of disease burden demonstrates the extent of the health burden for 
children with autism.  Additionally, the plots have the potential to reveal hidden clusters 
and interconnections that are difficult to observe in numerical summaries.  In these 
network plots, each medical condition is represented by a node, and two nodes are linked or 
tied together when patients share both medical conditions.  For the ease of visualization and 
interpretation, medical conditions ties are displayed when at least 3% of the sample shares 
the same two diagnoses.  For comparison, the network plots for diagnoses in children 
without an ASD diagnoses are also presented.  The data for a network plot uses a diagnosis 
and not a patient as the observation; the data here consists of 470 ICD-10 diagnoses, 167 for 
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children with autism and 319 for children without autism.  Diagnoses with only one 
occurrence were removed for clarity in the plots, leaving 247 diagnoses to be included, 77 
for children with autism and 219 for children without.  In addition to the plots, measures 
associated with the plots are also provided.  The normalized degree of centrality provides a 
measure of connectedness with the other diagnoses (S. P. Borgatti and Everett, 2006).  In 
the context of medical diagnosis network, degree centrality is an index of exposure in a 
network that can be interpreted as the relatedness of conditions and allows for comparison 
of diagnoses networks for children with and without autism. 
All network plots were constructed in and analyzed with UCINET v. 6.385 with 
NetDraw package (S. Borgatti et al., 2006).  All other statistical analyses were performed 
using SAS v. 9.3 and R studio v.0.96.  P-values ≤0.05 were considered statistically significant. 
Results 
Among the 1,582 children included in this study, more than half of the children were 
aged 2-5 years old (55%) and male (58%) (Table 3-1).  The majority (78%) of the children 
were diagnosed with one or more medical conditions and approximately half had public 
(49%) or private insurance (45%).  The average dmft for children under 6 was 8.23 
(sd=4.47), and the average DMFT for children aged 12 or more was 4.36 (sd=5.35).  In this 
study, autism was the second most prevalent medical condition (42%) next to 
developmental delay (60%).  Overall, 715 (47%) had at least one mental and behavioral 
disorder (F00-F99), 303 (20%) were diagnosed with childhood autism (F84), and 339 
(21%) were healthy (i.e. no medical diagnosis).  Among the 339 healthy children, the 
majority (87%) of them were 4 years of age or younger, and had median dmft of 8 (IQR: 5-
11). 
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Compared to children without autism, children with autism were older (9.46 vs. 
6.00, p=<.0001), more likely to be male (77% vs. 53%, p=<.0001), had private insurance 
(57% vs. 42%, p=<.0001), and were classified as ASA II (i.e. patient with mild systemic 
diseases) (70% vs. 33%, p=<.0001).  When stratified by age, children aged 6-12 with autism 
had slightly lower dmft than children without an autism diagnosis (mean=5.13 vs. 5.94, 
p=0.0508) (Table 3-2). 
There were similarities in the medical diagnoses reported between children with 
and without a diagnosis of autism.  Children with and without an autism diagnosis shared 
the top four additional concurrently reported ICD-10 medical diagnoses; developmental 
delay (43% vs. 27%); intellectual disability/learning disorders (40% vs. 18%); speech delay 
(36% vs. 17%); and seizures (36% vs. 17%) (Table 3-3). 
The network plot of the medical diagnoses for children with autism was complex 
with more connected conditions while the plot for children without autism had fewer 
connected diagnoses (Figures 3-2a and 3-2b).  Children with autism were also affected by 
attention deficit hyperactivity disorder (ADHD) (14%), anxiety disorder (9%), and 
aggressive/behavioral/self-injurious issues (9%).  These diseases were less commonly 
observed in children without a diagnosis of autism.  In addition to mental and behavioral 
health problems, several children with autism also reported diagnoses of food allergies 
(14%), acyanotic/cyanotic congenital heart defect (6%), pneumonia (4%), and infectious 
diseases (4%).  Among children with autism, the network plot with autism appeared to have 
more connections compared to the network plot without autism (Figure 3-2a and Figure 3-
2c).  In the absence of autism, developmental delay, intellectual disability, and speech delay 
became the major player in the network.  The structure of the network also became 
simplified as the connection between autism and other diseases was removed. 
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In the network plot for children with autism, developmental delay, speech delay and 
intellectual disability were the conditions that exhibit the highest connectedness, while for 
those without a diagnosis of autism, developmental delay dominated the network by having 
at least twice the degree centrality as the other conditions (Table 3-4).  In a social network, 
an actor (e.g. a person) with high degree centrality implies a person who is central and 
influential by highly connected with many others.  For this data, highly central medical 
diagnoses would be those that demonstrate high tendency to predispose children to many 
other diseases, or the source of disease burden. 
Discussion 
This study takes a novel approach to evaluating pediatric disease patterns using 
network plots.  The approach is also known as the “non-categorical” approach where the 
disease burden is viewed as a whole as opposed to a list ranked by the disease prevalence 
(Stein et al., 1993).  Compared to the disease-specific method, this approach provides a 
better understanding of the co-morbidity burden by revealing the disease’s connections to 
other diseases.  For example, using the network plot, it can be easily seen that a large group 
of children with autism are not only affected by several mental and behavioral disorders but 
also have high connectedness with other diseases.  Moreover, in the network plot for 
children with autism, if the diagnosis of autism is removed from the picture, the co-
morbidity network is simplified with reduced disease connections (Figure 3-2c). 
The study shows that while children with autism do not exhibit a particular high 
rate of dental caries, the disease may predispose them to multiple other co-morbid health 
problems that made provision of health care difficult.  While the age-adjusted mean DMFT 
for young children (age<6) with autism is slightly higher than that of children without 
autism, the dmft and DMFT scores for older children with autism (age>=12) are generally 
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lower compared to the unaffected children (Table 3-2).  The result is in concordance with 
several studies that either show no difference in caries experience when comparing 
children with and without autism or better oral health status in children with autism 
(Fahlvik-Planefeldt and Herrstrom, 2001; Loo et al., 2008; Shapira et al., 1989; US 
Department of Health and Human Services, 2008).   
Although children with autism do not exhibit a particular high risk for dental caries, 
they are more likely to have unmet needs than children without special health care needs 
(Kogan et al., 2008).  One of the most commonly reported barriers for children with autism 
to obtain access to dental care is the children’s behavioral difficulties.  Children with autism 
have unusual sensory to the stimuli from the environment which may greatly interfere with 
the dental procedure during the course of a treatment (Charles, 2010).  In this study, the 
network plots demonstrate a high degree of interconnectedness to diagnoses such as 
developmental delay, intellectual disability, speech delay, and seizure disorders that are 
associated with challenges in engaging a child’s cooperation sufficiently to safely perform 
complex restorative treatment.  Due to their difficulty to manage sensory input from the 
environment, additional efforts such as providing care from the same dentist, in the same 
service facility, and consistent appointment times are necessary (Charles, 2010).  It not only 
requires patience, but also knowledge of the children’s disability, understanding the degree 
of their related medical and behavioral conditions, and accommodations in the medical 
facility (American Academy of Pediatric Dentistry Council, 2005; Charles, 2010) to 
efficiently provide oral health care to pediatric patients with autism.  Other barriers for 
children with autism in getting access to oral health care include high dental treatment cost 
and lack of insurance (Lai et al., 2012). 
Unlike other studies, the population in this study consists of children with severe 
dental conditions as well as significantly compromising medical conditions which provide a 
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unique opportunity to examine the complication of oral health status and dental need of 
pediatric patients beyond autism.  The study shows that children with autism are referred 
to a hospital for dental surgery because of their complex medical histories.  Specifically, 
children with autism are also more likely to be affected by 1) developmental delay, 2) 
speech delay, and 3) intellectual disability.  The occurrence of these diseases is at least twice 
as common as children without autism (Table 3-3).  While children with autism carry 
multiple other medical conditions, the majority (70%) of them are ASA II (i.e. patient with 
mild systemic diseases) instead of ASA III (i.e. patient with severe systemic diseases).  In 
fact, comorbid psychiatric conditions such as intellectual disability, and impaired language 
comprehension are common among children with autism (Autism and Developmental 
Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators, 2007; 
Charles, 2010).   These additional mental and behavioral comorbid conditions associated 
with autism compromise children’s ability to follow directions and mimic instructions 
effectively.  Due to these impairments, significantly more children with autism are reported 
to be uncooperative at their visit to the dentists compared to healthy children (Loo et al., 
2008; Marshall et al., 2007).  Thus, it is recommended that autistic children with oral health 
problems receive dental treatment under general anesthesia in a fully equipped hospital 
facility so that the dental procedures can be performed safely and effectively (Ganem, 2011; 
Jaber, 2011).  Particularly, since children with autism are more likely to have multiple 
concurrent disorders, they require broader range of services.  It is necessary for them to go 
to a health care site that provides all of the care they need (Mathu-Muju et al., 2013).  To 
meet the larger demand of such services, it is necessary to divert resources to hospitals and 
support insurance plans to cover costs of dental care including general anesthesia fee.  By 
doing so, waiting times, and the cost of general anesthetic care could potentially be reduced, 
thereby improving the efficiency of care for CSCHN (Lewis, 2009; Mathu-Muju et al., 2013).  
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Studies have shown that families with children affected by autism could have more 
financial burden due to higher health care services utilization and more specialized care 
needs compared to typically developing children (Kogan et al., 2008; Newacheck and Kim, 
2005).  Their medical expenses may include co-payments, deductibles, premiums, 
specialized learning programs and uncovered health services such as dentistry.  These 
expenditures add up quickly creating a great financial burden for the family providing care 
for children with autism and complex medical needs.  For example, the national survey 
shows that approximately 40% of families of children with autism reported having financial 
problems by taking care of their children (The National Survey of Children with Special 
Health Care Needs Chartbook 2005–2006).  Moreover, families with children affected by 
autism often need to compromise their work hours or stop working to take care of their 
children (Casamassimo et al., 2009; Kogan et al., 2008), creating additional financial stress 
to the family. Therefore, developing and implementing affordable dental plan programs and 
comprehensive coverage to support services for children with autism is critically important.  
To our knowledge, it is the first time that social network plots are used to describe 
the pattern of co-morbidities and explore the clinical heterogeneity of children with autism.  
The network plot, instead of focusing on individual diagnoses, emphasizes the relations 
between diagnoses.  While these techniques provide unique visual exploration of children’s 
co-morbidity network, there are also several limitations.  For example, the network plot is 
limited to pair-wise associations only.  For children with three or more diseases, patterns of 
multitudes of disease can only be captured in a group of two diseases at a time.  Therefore, 
one cannot tell if a triangle formed by connecting three disease nodes in a network plot 
implies children having a combination of two or three different diseases.  However, given 
the goal of the study is to focus on the most prevalent combinations, the fact that we capture 
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the most frequent occurring combinations in any two diseases allows us to narrow down 
from all of the possible combinations. 
It must be noted that there is no rapid solution to accommodate and alleviate the 
future demand for dental services under general anesthesia for pediatric patients.  Current 
issues that must be addressed include lack of anesthesia and operation-room (OR) staff 
(Lewis and Nowak, 2002), and high rates of hospital OR cancellations (Schroth and Morey, 
2007).  Above all, it is also essential for pediatric dentists to consider different variables that 
may influence the dental needs of young children in the provision of such services.  
Ultimately, the best way to address the needs of this vulnerable population is through the 
participation of all stakeholders to improve access to early preventive care and promote 
correct oral health care practices.  
In conclusion, while children with autism do not necessarily exhibit worse dental 
caries compared to those without the disease, the study shows that affected children have 
much more complicated medical histories and other mental and non-mental behavioral 
disorders that require comprehensive care and more efficient oral health services at 
hospital facility.  Therefore, strategies to increase public funding of general anesthesia costs 
as well as training to treat children with autism should continue to be a priority for 
stakeholders and policy makers to promote oral health of children with autism. 
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Figure 3-1. Flow chart of study design 
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Table 3-1. Overall Demographics  
 Children 
without autism 
Children 
with autism 
P-value 
All 1279 303  
Age (mean, sd) 6.00 (4.30) 9.46 (4.04) <.0001 
Gender   <.0001 
Male 682 (53%) 234 (77%)  
Female 597 (47%) 69 (23%)  
Age   <.0001 
1-5 824 (64%) 49 (16%)  
6-12 304 (24%) 177 (58%)  
>12 151 (12%) 77 (25%)  
Payment 
method 
  <.0001 
Self 91 (7%) 17 (6%)  
Public 652 (51%) 114 (38%)  
Private 532 (42%) 172 (57%)  
Region   0.0008 
Vancouver 1099 (86%) 282 (93%)  
Not Vancouver 180 (14%) 21 (7%)  
# Diagnosis   <.0001 
0 339 (27%) 0 (0%)  
1-4 609 (48%) 172 (57%)  
5-9 268 (21%) 113 (37%)  
10+ 44 (3%) 18 (6%)  
ASA   <.0001 
I 530 (42%) 11 (4%)  
II 417 (33%) 213 (70%)  
III 328 (26%) 79 (26%)  
 
 
Table 3-2. Children’s caries experience by age 
 All No Autism Autism  
N 1582 1279 303  
 Mean (sd) Mean (se) Mean (se) p-value 
Age<6     
N 873 824 49  
dmft 8.23 (4.27) 8.23 (0.15) 8.24 (0.61) 0.9818 
6-12     
N 481 304 177  
dmft 5.64 (4.38) 5.94 (0.22) 5.13 (0.29) 0.0508 
DMFT 1.44 (2.46) 1.54 (0.12) 1.26 (0.16) 0.1794 
>12     
N 189 151 77  
DMFT 4.36 (5.35) 4.48 (0.44) 4.11 (0.62) 0.5982 
Note: dmft and DMFT are the decayed, missing and filled teeth observed in the primary and 
permanent teeth, respectively. 
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Table 3-3. Most common medical diagnoses associated with children with and without 
autism 
Rank Children without 
autism 
N=1582 Children with 
Autism 
N=303 
1 Developmental delay 423 (27%) Developmental delay 129 (43%) 
2 Intellectual 
disability/Learning 
disorders 
285 (18%) Intellectual 
disability/Learning 
disorders 
120 (40%) 
3 Speech delay 268 (17%) Speech delay 110 (36%) 
4 Seizure disorders 237 (15%) Seizure disorders 61 (20%) 
5 Hypersensitivity/Allergy 
– Meds 
196 (12%) Attention deficit 
hyperactivity 
disorder  
42 (14%) 
6 Hypersensitivity/Allergy 
– Food 
177 (11%) Hypersensitivity/Alle
rgy – Food 
42 (14%) 
7 Asthma 163 (10%) Hypersensitivity/Alle
rgy – Meds 
36 (12%) 
8 Vision problem 
(glaucoma, cataract) 
126 (8%) Epilepsy 34 (11%) 
9 Acyanotic/cyanotic 
congenital heart defect 
111 (7%) Asthma 29 (10%) 
10 Cerebral Palsy 97 (6%) Anxiety disorder 28 (9%) 
Note: ICD 10 codes were used to create the diagnoses and the names of the diagnoses have 
been shortened for ease of viewing. 
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Figure 3-2a. Network plot for children with autism 
 
Note: ICD 10 codes were used to create the diagnoses and the names of the diagnoses have 
been shortened for ease of viewing. 
 
Figure 3-2b. Network plot for children without autism 
 
Note: ICD 10 codes were used to create the diagnoses and the names of the diagnoses have 
been shortened for ease of viewing. 
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Figure 3-2c. Network plot for children with autism (without the diagnosis of autism on the 
plot) 
 
Note: ICD 10 codes were used to create the diagnoses and the names of the diagnoses have 
been shortened for ease of viewing. 
 
Table 3-4. Normalized degree centrality for the network plot of children with and without 
autism 
Children with Autism Normalized 
centrality 
Children without autism Normalized 
centrality 
Autism 23.7 - - 
Developmental delay 18.4 Developmental delay 9.6 
Speech delay 14.5 Speech delay 3.8 
Intellectual disability/Learning 
disorders 
14.5 Intellectual 
disability/Learning 
disorders 
3.8 
Seizure disorders 9.2 Seizure disorders 6.7 
Asthma  6.6 Asthma  1.0 
Epilepsy 6.6 Epilepsy 1.9 
Attention deficit hyperactivity 
disorder 
6.6 Attention deficit 
hyperactivity disorder 
0 
Hypersensitivity/Allergy - 
Food 
5.3 Hypersensitivity/Allergy - 
Food 
0 
Hypersensitivity/Allergy - 
Meds 
5.3 Hypersensitivity/Allergy - 
Meds 
1.9 
Note: ICD 10 codes were used to create the diagnoses and the names of the diagnoses have 
been shortened for ease of viewing. 
Copyright © Hsin-Fang Li 2013 
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Chapter Four 
An Environmental-Wide Association Study (EWAS) on Periodontitis using NHANES 
 
Introduction 
Despite increasing awareness and improvement in oral health, periodontitis, 
together with dental caries, remain the greatest oral health concerns in the United States 
(Benjamin, 2010).  
Periodontitis is inflammation of the gums caused by the accumulation of bacterial 
plaque (Michaud et al., 2007; Pihlstrom et al., 2005).  The disease is a threat to oral health 
since it can progress to destroying the periodontal tissue and bone, and eventually leads to 
tooth loss if it is not treated in time (Bartold et al., 2010).  While the disease ranges from 
mild (known as gingivitis) to chronic and severe, the biological mechanisms for the disease 
development are very similar (Bartold et al., 2010).  The disease is believed to initiate with a 
large accumulation of microbial species in the mouth and on the teeth adjacent to the gums 
(gingival) (Pihlstrom et al., 2005).  Among a wide variety of bacterial species found in the 
mouth, Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola, known as 
the “red-complex” bacteria, are found responsible for the most severe form of periodontal 
diseases (Socransky et al., 1998).  However, these microbial agents are not sufficient to 
affect the supporting structure of the teeth without an inflammatory response associated 
with the disease to take place first (Bartold et al., 2010).  The inflammation is triggered 
when the number of bacteria increases to a state; at the same time, the inflammatory 
cytokines are also released.  The inflammatory cytokines will enhance osteoclast activity 
and initiate the bone resorption process (Bartold et al., 2010).  Osteoclasts are 
multinucleated cells that can effectively dissolve alveolar bone (tooth-supporting bone) by 
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releasing de-mineralizing agents and degrading enzymes (Schwartz et al., 1997; Teitelbaum, 
2000).  As a result of the continuous destruction of the alveolar bone and periodontal soft 
tissues, teeth may become loose and finally lost.  Periodontal diseases are known to be the 
major source of tooth loss in adults (Darveau, 2010; Horton et al., 1972; Petersen et al., 
2005).  People without teeth have difficulty eating, swallowing, and speaking properly.  The 
impaired oral function can greatly impact their quality of life and continues to grow as a 
public health concern and problem.  A study examining Japanese health care enrollees aged 
40-59 suggested that the patients suffering from severe peridontitis had predominantly 
more hospital visits and higher health care costs, and were also more likely to have higher 
medical care costs for chronic diseases (Ide et al., 2007).  
It has been well documented that periodontal diseases result from the interplay of 
both environmental factors and socio-behavioral factors (Albandar, 2002; Van Dyke and 
Dave, 2005).  For example, smoking, low social economic status, poor oral hygiene, 
psychological stress, depression, increased age, Hispanic ethnicity, environmental toxins 
and systemic health outcomes are well known risk factors that may aggravate the 
progression of periodontal diseases (Albandar, 2005; Pihlstrom et al., 2005; Stabholz et al., 
2010).  Among them, smoking is the most significant and modifiable risk factor in the 
pathogenesis of periodontitis (Bergström and Preber, 1994).  Not only does tobacco use 
have a detrimental effect on periodontal health, the number of cigarettes smoked per day is 
also directly related to the prevalence and the severity of the disease (Martinez‐Canut et al., 
2005; Tomar and Asma, 2000).  Studies have also demonstrated that individuals under 
psychological stress may have lower immune system functions to respond to inflammation 
and infections, thereby more likely to experience attachment loss and loss of the alveolar 
bone (Hugoson et al., 2002; Wimmer et al., 2002).  Other modifiable factors such as oral 
hygiene practices, environmental exposures, and diet are also considered important risk 
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factors that can be treated and controlled (Van Dyke and Dave, 2005); other non-modifiable 
factors include aging and systemic diseases (Van Dyke and Dave, 2005).  Despite 
environmental factors, healthy individuals may be more susceptible to develop periodontal 
diseases due to genetic predisposition (Dumitrescu and Kobayashi, 2010).  
Based on GWAS (genome-wide association studies) methodology, Patel et al (2010) 
proposed a two-step approach to conduct environmental-wide association studies (EWAS) 
or an epidemiological analysis of a large number of environmental “loci".  In the two-step 
approach, the first step is to test each environmental factor with the intention of producing 
a smaller subset of factors with high associations with the disease.  Unfortunately, the 
strategy falsely assumes that significant interactions affecting the outcome can only happen 
between independent variables with a detectable effect, a common problem in GWAS 
(Turner et al., 2010).  In addition, when the factors are correlated, which is highly plausible 
for this set of many environmental variables, the correction for significance level becomes 
less efficient in assessing the dependencies between them (Moore et al., 2010).  
Alternatives to this approach are becoming more popular in GWAS literature and 
may offer a better analytical solution to EWAS studies; combinatorial partitioning method 
(CPM) (Nelson et al., 2001), multidimensional reduction (MDR) (Motsinger and Ritchie, 
2006), and random forests (Breiman, 2001; Strobl et al., 2009) are methods that are used 
with large multidimensional data.  In particular, random forests are capable of handling and 
reducing a large number of predictors by evaluating the important contribution to outcome 
while taking care of non-linear and correlated variables and may be ideally suited for 
exploring the relationship between environmental factors and health outcomes (Goldstein 
et al., 2010; Grömping, 2009; Lunetta et al., 2004; Moore and Williams, 2002).  
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Periodontitis is a multi-factorial disease in that genetics, microbiology, health 
behaviors, and environmental toxins all contribute to the development of the disease 
(Albandar, 2002; Albandar and Rams, 2002).  The progression of the disease is affected by 
both the modifiable factors (e.g. behavioral, diets, environmental, etc) and non-modifiable 
factors (e.g. genetics), as well as the interactions among them (Meisel et al., 2003; Mucci et 
al., 2005; Van Dyke and Dave, 2005).  Therefore, to investigate the association of potential 
environmental factors on a broad scale, EWAS methodology is appropriate.  However, 
through the use of random forests and classification and regression trees, these factors can 
be examined in the presence of a wide spectrum of correlated environmental variables that 
may be moderated by other known risk factors.  To our knowledge, this is the first use of 
random forests to investigate the highly correlated environmental variables collected 
through NHANES.  This tree-based method was selected for its ability to allow 
nonlinearities and interactions without modeling them explicitly.  In addition, the advanced 
version of random forests, which we employed, also handles missing values easily 
(Hapfelmeier et al., 2012).  These unique features are essential in this application as the 
structure of NHANES collection results in missing data, potential predictors might be 
associated in some non-linear fashion, and interactions are likely to play a major role.  
Methods 
Data from the National Health and Nutritional Examination Survey (NHANES) were 
used for this study. NHANES is a biannual population based survey conducted by the 
Centers for Disease Control and Prevention (CDC) (Centers for Disease Control and 
Prevention, 2009).  The survey includes interviews, examinations, laboratory tests based on 
blood and urine samples.  In addition to rich demographic background information, the 
database also provides a wide variety of environmental exposures assessments and a 
comprehensive measure of oral health data from the adult population in the United States.  
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The study included survey data collected in 1999-2000, 2001-2002, and 2003-2004.  The 
eligible subjects in this study were those with age of 18 or older with at least 16 teeth 
present (Akalin et al., 2004; Baelum et al., 1993; Lappin et al., 2007; Needleman et al., 2007; 
Rosling et al., 1997), resulting in an overall sample size of 10,278.  Since smoking is one of 
the greatest risk factors for periodontitis (Amarasena et al., 2002; Heikkinen et al., 2008; 
Laxman and Annaji, 2008; Tomar and Asma, 2000), the data were further stratified into 
three groups based on the smoking categorization: current smokers, former smokers and 
nonsmokers.  Smoking status was derived from the two self-reported questions: 1) “Do you 
now smoke cigarettes?”, and 2) “Have you smoked at least 100 cigarettes in life?”  
Participants who responded “smoking every day” or “smoke some days” and who had 
smoked at least 100 cigarettes were defined as current smokers (n = 2150); participants 
who reported having smoked more than 100 cigarettes but were currently not smoking 
were defined as former smokers (n = 2421); participants who reported never smoked were 
defined as nonsmokers (n = 5707).  
Laboratory and Environmental Measures 
The laboratory component of NHANES measures the specific environmental 
attributes that include chemical toxicants, pollutants, allergens, bacterial/viral organisms 
and nutrients using blood and urine samples.  The environmental factors were categorized 
into 15 environmental classes based on NHANES categorization.  The environmental 
variables measured in at least one of the three cycle data (i.e. 1999-2004) were included in 
the study.  Variables measuring bacteria and virus infections were excluded.  A total of 156 
environmental were identified; the variable names as well as their classification were listed 
in Supporting Material – Table S-1 and S-2.  Since majority of variables were measured by 
mass spectrometers or absorption spectroscopy, the measurements laid in small ranges and 
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were skewed.  Therefore, these variables were (natural) log-transformed and standardized 
(subtracting each observation by its mean and scaling by the standard deviation).  These 
logged and standardized variables are referred to as the “processed” variables hereafter.  
Laboratory measurements that had a majority (>90%) of the observations below a 
detection limit threshold defined by the NHANES codebooks were omitted.  
Oral Health Measures 
Oral health data has been collected as part of the component in NHANES since 1959 
(except for NHANES II, 1976-1980).  Oral health information were collected in two ways: 
home interview and physical dental examination.  During the home interview, surveys 
regarding dental health perception, dental visits, dental care utilization and other oral 
health conditions were administered by trained home interviewers.  Physical dental 
examinations including tooth count, different types of caries, and periodontal assessment 
were completed in the medical examination center (MEC) by health professionals and a 
licensed dentist.  The periodontal assessment is only performed for persons older than 18 
with more than 16 teeth in year 1999-2000 and 2001-2002, respectively.  In the periodontal 
evaluation, the dental examiner randomly chooses two quadrants of the mouth, namely one 
upper and one lower on either side of the mouth. Unlike the full-mouth periodontal 
examination (FMPE), NHANES uses the partial-mouth periodontal examination (PMPE) 
protocol to sample teeth and sites.  The PMPE protocols randomly selects two quadrants of 
the mouth and specified 2 to 3 sites per tooth for measurement of pocket depth, attachment 
loss, bleed on probing. In 1999-2000, two sites per tooth (mid-facial and mesio-facial) were 
measured; three sites per tooth (mid-facial, mesio-facial and distal) were measured in 
2001-2002 and 2003-2004. 
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A periodontal site is defined as a pocket site with ≥ 3 mm CAL and ≥ 4 mm PD 
(Health and Human Services Vital and Health Statistics Series 11 Report).  The gold 
standard of diagnosing periodontitis using full-mouth examination protocol yields an 
approximated prevalence of 22.4% (P. I. Eke et al., 2010; Page and Eke, 2007).  The half-
mouth (16 teeth) examination protocol utilized by NHANES is known to underestimate the 
national prevalence rate since periodontitis is site-specific and not evenly distributed in the 
mouth (P. I. Eke et al., 2010).  Thus, case definition of Series 11 was chosen because it 
yielded an estimate (16.9%) in NHANES 2001-2004 that was closest to the gold standard.  
Demographic characteristics 
The demographic variables considered in this study included age, gender, race, 
socio-economic status, smoking status, and number of teeth. Racial groups were 
summarized into five categories: Mexican American, Other Hispanic, Non-Hispanic White, 
Non-Hispanic Black, and Other Race.  Socio-economic status, estimated using the poverty 
income ratio, was computed as the ratio of family/individual income to the appropriate 
federal poverty threshold.  Smoking status was derived from the two self-reported 
questions described previously; participants to reported having smoked more than 100 
cigarettes but were currently not smoking were defined as former smokers; participants 
who reported never smoked were defined as nonsmokers.  
Statistical Analysis 
In this study, three NHANES datasets (1999-2000, 2001-2002, and 2003-2004) 
were extracted and combined to create data with multiple years.  Among the 11,041 
participants who were older than 18 years of age and had at least 16 teeth, 3485 were 
collected in the first cohort (1999-2000), 3988 in the second cohort (2001-2002), and 3568 
in the third cohort (2003-2004).  Those with missing smoking status were excluded leaving 
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the final analytical sample of 10,278 participants.  Weights for the combined dataset were 
recomputed.  With periodontal case definition described earlier, the survey-weighed case 
prevalence was 8.1%, 8.9%, and 3.7% in year 1999-2000, 2001-2002, and 2003-2004.  The 
overall (1999-2004) prevalence of periodontitis was 6.9%. 
Among the 10,278 individuals who were older than 18 years old and had at least 16 
teeth, over half of them were nonsmokers (55%), followed by former smokers (23.6%) and 
current-smokers (20.9%) (Table 4-1).  Descriptive analysis was performed to describe the 
demographic information between 1) three smoking groups (current/former/none 
smokers), and 2) the periodontitis status (yes/no).  Continuous variables were summarized 
using descriptive statistics (n, mean±SD).  Categorical variables were summarized using 
frequencies and percentages.  
Survey-weighted logistic regressions were performed for each of the log-
transformed environmental factors, adjusting for age, gender, ethnicity, socio-economic 
status, smoking status and number of teeth; adjusted odds ratios are presented with 95% 
confidence intervals overall and by smoking status to demonstrate the relationship between 
the individual factors and periodontitis.  Correction for multiple hypothesis testing was 
performed with Benjamini-Hochberg false discovery rate (BH FDR) procedure (Benjamini 
and Hochberg, 1995) (refer to Appendix A for detail).  We used a FDR of 5% in the 
aggregated cohort to select significant associations, which corresponds to a significance 
level of 0.01.  
This EWAS analysis employed random forests (RF) and classification and regression 
trees (CART) to investigate associations and potential interactions between environmental 
factors, demographic and socioeconomic characteristics, and periodontitis disease status 
(refer to Appendix B for detail).  Specifically, RF was used to identify important factors 
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(main effects and interactions) and CART was used to investigate these relationships.  These 
methods were selected because the data involved many potentially correlated 
environmental factors and had the ability to allow nonlinearities and interactions without 
modeling them explicitly.  
Classification and Regression Trees 
Tree-based methods (like CART) are non-parametric, and differ from more 
traditional regression models is the modeling structure.  Regression models are known as 
the main-effect model where all variables are fit in a single model, and their relationships 
with the response are evaluated simultaneously.  In order to justify the use of regression 
models, several principal assumptions such as linearity between the outcome and the 
predictors, constant variance of the errors and normality of the error distribution must 
hold.  In contrast, tree-based methods are assumption-free and examine the influence of 
predictor variables sequentially.  That is, the relationship between the predictor variables 
and the outcome in a specific group is only assessed given that the observations met certain 
criteria.  As this process continues, the combinations of factors can be easily visualized by a 
tree-like plot.  The hierarchical nature of the model enables the identification of 
interactions. 
Classification and regression trees are tree-based methods that attempt to identify 
high-risk groups by selecting a set of predictors that classify observations into partitions 
with and without the target outcome.  CART is a method that identifies the best classifying 
variable and then splits the sample based on a criterion that best separates according to 
whether or not the outcome of interest (periodontitis) is present.  The best splitter variable 
is chosen by evaluating the association between responses and each covariate via 
permutation tests.  The split criteria can be again established using the permutation test 
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framework (Hothorn et al., 2006).  This partitioning process is carried out recursively until 
no further classification is necessary. The variable selection process is carried out through a 
hypothesis testing procedure (Refer to Hothorn 2006 for mathematical detail).  In the CART 
model, we included the “significant” log-transformed environmental factors as well as 
demographic and socio-behavioral factors (age, gender, ethnicity, socio-economic status, 
and number of teeth).  To avoid over-fitting and bias variable selection in the conventional 
splitting criteria such as Gini’s index, conditional inference tree is chosen and was 
conducted using Rv2.14.1 with the party package.  
Random Forests 
Random forests were first introduced as an extension of a single decision tree (i.e. 
classification regression tree) proposed by Breiman (2001) and used a collection of 
individual trees to improve prediction errors.  Although CARTs are simple and easy to 
implement, the major disadvantage is the instability to small data changes.  The problem 
occurs when small changes in the dataset from the preceding partition affect the 
subsequent partitioning extensively.  Thus, the predictors selected from a single tree may 
not be deemed reliable.  The alternative is to consider a collection of trees (a.k.a. random 
forests) each formed by a random sample of observations and a random sample of 
predictors.  The goal is to reduce the classification prediction error by taking the majority of 
the vote for classification and average for regression.  
In a forest, each tree is “grown” using a random sample of the original dataset 
without replacement.  The procedure is known as bagging where the observations were 
drawn randomly from the original data set (i.e. in-bag samples) are used to predict the 
outcome of the “out-of-bag” observations (Breiman, 1996).  The rationale behind bagging is 
that the results obtained from the aggregation process are no longer affected by a specific 
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choice of the data.  Additionally, within each tree, each node is split based on a subset of a 
random selection of predictors.  This is critically important and different from the standard 
trees, where nodes are split using the best splitting variable among all variables.  In 
contrast, the random selection of predictor variables addresses the issues of multi-
collinearity and overshadowing (when the effect of a weaker predictor is overlooked by 
more significant competitors).  The benefit of randomly selecting predictors at each split is 
to reduce the competition between similarly important and correlated factors.  As a result, 
this step adds an extra layer of randomness in addition to bagging to produce even more 
diverse trees and further improves the predictive performance (Breiman, 2001).  Hence, 
there are two parameters in random forests: number of trees grown (ntree) and number of 
predictor variables considered in the splitting process (mtry).  The default number of trees 
is 500 and the suggested number of mtry has a default of the sqrt(the number of predictors) 
for classification forests (Breiman, 2001). 
In this random forest model, all 156 log-transformed environmental variables (i.e. 
log-transformed and standardized) as well as 5 socio-demographic variables (age, gender, 
ethnicity, socio-economic status and number of teeth) were included.  With p=161 variables 
in the model, mtry (number of splitting variables) was chosen to be 13 (i.e. sqrt(161)=13), 
and a total of 500 trees were grown for each model.  Conditional inference trees were used 
in this study to ameliorate the bias due to the presence of highly correlated variables (Strobl 
et al., 2008; Strobl et al., 2009; also see section 3.4 for detail discussion).  The contribution 
of a variable, which may be due to its interactions with other variables, is measured based 
on the increase in misclassification when the variable is excluded from the model, averaged 
overall all trees (Refer to Appendix B for detail).  Variables are considered informative and 
important if the misclassification error is larger than a certain threshold.  In this study, we 
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take the absolute value of the lowest negative-scoring variables as the cutoff point (Shih, 
2011).  Random forests were performed using Rv2.14.1 with the party package.  
Results 
Population Characteristics 
The analytical set contained 10,278 individual who were older than 18 years old 
and had at least 16 teeth.  Over half of them were nonsmokers (53.5%), followed by former 
smokers (23.3%) and current-smokers (23.2%) (Table 4-1).  The majority of the sample 
population were non-Hispanic white (71.0%), and approximately 43% of the sample 
population were between 31-49 years old. 
Periodontitis, defined as having at least a pocket site with ≥ 3 mm CAL and ≥ 4 mm 
PD, prevalence was 6.9%.  Compared to persons unaffected by periodontitis, individuals 
with periodontitis were more likely to be male (62% vs. 48%, p<.0001), Non-Hispanic Black 
(10% vs. 20%, p<.0001), aged greater than 30 (71% vs. 89%, p<.0001), current smokers 
(39% vs. 22%, p<.0001), and had lower socio-economic status (mean=3.11, se=0.05 in 
control vs. mean=2.48, se=0.09 in cases, p<.0001) (Table 4-2). 
The results of the individual survey-weighted logistic regressions for the overall 
sample and stratified by smoking status were shown in Table S-3 and Table 4-3, 
respectively.  In the overall sample, 49 factors (including 6 heavy metals, 7 nutrients, 8 
hydrocarbons, and 20 PCBs) resulted in statistically significant odds ratios.  When the data 
was stratified by the smoking status, 17 (2 heavy metals, 1 nutrient, 8 PCBs, 1 pesticide, 2 
phthalate, 1 photo-estrogen, and 2 dioxins), 15 (1 heavy metal, 1 nutrient, 10 PCBs, 2 
pesticides, and 1 phthalate), and 7 (2 heavy metals, 4 PCBs, and 1 diakyl) environmental 
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factors were identified for current smoker, former smoker, and nonsmoker groups, 
respectively.  
For the overall sample, several nutrients were found to be protective of 
periodontitis.  These included the carotenoids (a[ORs] between 0.79-0.84), serum folate 
([a]odds ratio=0.79, 95% CI: 0.71-0.90) and red blood cell folate ([a]odds ratio=0.83, 95% 
CI: 0.75-0.92); vitamins g-tocopherol and retinyl stearate  increased odds of periodontitis, 
a[OR]=1.6 (95% CI: 1.05-1.27) and a[OR]=1.17 (95% CI: 1.06-1.30), respectively.  Lead in 
blood (PbB) was consistently identified as the risk factor in both the overall and stratified 
analysis; the adjusted odds ratio estimates range from 1.34 (95% CI: 1.13-1.57) for 
nonsmokers to 1.57 (95% CI: 1.28-1.93) for former smokers.  Nonsmokers were also 
affected by antimony (in urine) ([a]odds ratio=1.49, 95% CI: 1.27-1.74).  The effect of 
cadmium ([a]odds ratio=1.31, 95% CI: 1.10-1.56), dioxin 1,2,3,7,8-pncdd (a[OR]=1.60, 95% 
CI: 1.14-2.25),  and dioxin 2,3,7,8-pncdd (a[OR]=1.75, 95% CI: 1.20-2.58) were only 
significantly associated with periodontitis among current smokers.  Additionally, two types 
of the phthalates (mono-n-methyl and mono-n-octyl) were found to increase the odds of 
periodontitis among smokers and mono-n-octyl phthalate was also significantly related to 
increased odds of periodontitis among former smokers; this relationship did not exist in 
nonsmokers. 
Among the 20 polychlorinated biphenyls (PCBs) found to be associated with 
periodontitis in the overall sample, 7 (i.e. PCB105, PCB146, PCB172, PCB177, PCB178, 
PCB183, and PCB206) were also found significant in both current smokers and former 
smokers.  Compared to current smokers, the effect of these PCBs appears to be greater 
among former smokers.  The adjusted odds ratios range from 1.55 to 3.41 among current 
smokers and 1.87 to 5.75 among former smokers.  For nonsmokers, 4 types of PCBs were 
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significantly related to periodontitis, and these effects were much smaller compared to that 
of current and former smokers. 
Random Forests 
For the ease of interpretation, the top 50 log-transformed environmental variables 
with the largest variable importance (VI) index were plotted in Figure 4-1a-d; the variables 
with a positive VI imply a positive contribution to the random forest model.  For the overall 
sample, all of the demographic variables (i.e. age, race, gender, and ses) were ranked as the 
most important variables based on the VI indices (Figure 4-1d).  Additionally, PbB, 
phthalates (mono-cyclohexyl phthalate and mono-n-octyl phthalate), cotinine, nutrients 
(cis-b-carotene, folate RBC, retinyl stearate), and pcbs (pcb170 and pcb206) were also 
selected as important factors associated with increased rate of periodontitis. 
Among smokers, PbB, retinyl stearate, and phthalates were identified in the random 
forest model in additional to age, race, and SES (Figure 4-1a & Table 4-3).  Among former 
smokers, the variables with VI indices were (in order) race, a-Tocopherol, PbB, gender, SES, 
cotinine, Red Blood Cell (RBC) folate, and age (Figure 4-1b & Table 4-3).  Among 
nonsmokers, only cis-b-carotene and antimony (in urine) selected as important variables in 
addition to age, gender and race (Figure 4-1c & Table 4-3).  
Classification and Regression Trees 
For the variables selected using RF, classification regression trees were plotted for 
each of the smoking group (Figure 4-2a, 4-2b, and 4-2c).  In the CART model, processed 
variables with p-value less than 0.01 and the five demographic covariates (i.e. age, gender, 
race, socio-economic status, and number of teeth) were considered. 
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For current smokers, PbB, age, and retinyl stearate were considered as the major 
classifier for periodontitis.  Figure 4-2a suggested that those who have standardized-log 
PbB level of more than 0.556 μg/dL and standardized-log retinyl stearate of over 0.017 
μg/dL had the highest rate of periodontitis (~25%). For those with standardized-log PbB 
level less than 0.556 μg/dL but aged over 35, the prevalence of periodontitis was also high 
(~18%).  
For former smokers, most of the demographic variables (e.g. age, gender, and race) 
were important classifiers (Figure 4-2b).  There were three groups with noticeably high 
prevalence of periodontitis (i.e. 15% or higher): 1) individuals who were non-white, had 
standardized-log blood Lead level of less than 0.356 ng/mL, and male, 2) individuals who 
were non-white, had standardized-log blood Lead level of more than 0.356 ng/mL, and 3) 
individuals who were White or multi-racial, male, and had income poverty ratio less than 
1.79.  Conversely, those who are White and female had the lowest prevalence of 
periodontitis (less than 5%). 
Among nonsmokers, figure 4-2c suggested that the risk factors were a mixture of 
demographic variables (e.g. race, gender and SES) and environmental variables (e.g. 
Antimony and cis-Beta carotene).  Specifically, the subgroups that exhibited a prevalence 
rate of 15% or higher were those who were 1) non-White, aged more than 29, and had 
standardized-log Antimony level of more than 0.705 ng/mL, 2) non-White, aged more than 
29, had standardized-log Antimony level of less than 0.705 ng/mL but standardized-log cis-
Beta carotene less than 0.672, regardless of their gender. 
Discussion 
This study found that well-known risk factors (e.g. Lead, cotinine, age, gender, ses, 
and race) as well as several environmental variables PCBs, dioxins, phthalates and nutrition 
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were potential risk factors for periodontitis.  Among the environmental factors identified, 
several nutrients (such as carotenoids, serum folate, red blood cell folate, vitamins g-
tocopherol and retyinyl stearate), phthalates (plasticizers), dioxins and various PCBs are 
novel findings.  In addition to identifying potential risk factors, results from CART show that 
certain combinations of demographic and environmental variables can effectively classify 
individuals based on prevalence rates of periodontitis.  EWAS methodology, enhanced by 
random forests, allowed for the reduction of a high dimensional dataset to a smaller set so 
that predictors’ contribution to disease could be evaluated more closely.  To our knowledge, 
this is the first use of random forests and CART to analyze NHANES data as well as to 
investigate periodontal disease.  Despite of the smoking background, stratified analysis 
from RF analysis shows that individuals’ demographic variables (e.g. age, gender, race, and 
ses) were also important predictors of the disease.  
Over the past decade, smoking has also been noted as one of the most significant 
risk factors that affect people’s periodontal health, and its detrimental effects has been 
highlighted in numerous studies (Amarasena et al., 2002; Heikkinen et al., 2008; Laxman 
and Annaji, 2008; Tomar and Asma, 2000).  
Cotinine, a major metabolite of nicotine and an alkaloid found in tobacco (Zenzes et 
al., 1996), has been commonly used as a marker of active smoking (Jarvis et al., 1987).  It 
can also be used to distinguish those who exposed and not exposed to Environmental 
Tobacco Smoke (ETS) among nonsmokers (Haufroid and Lison, 1998).  Since the half-life of 
cotinine is longer than that of nicotine (15-20 hours vs. 0.5-3 hours), cotinine has been 
commonly used as a mediator of tobacco smoke usage (Benowitz, 1983; Kyerematen et al., 
1990).  While the half-life of cotinine in serum, urine and saliva is similar (Jarvis et al., 
1988), serum is mostly commonly chosen to assess quantitative exposure (Armitage et al., 
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1975), and also the choice of fluid in the NHANES cotinine analyses.  In this study, cotinine 
was selected as a significant risk factor among former smokers (by random forests) but not 
among other groups.  This may due to the fact that the variability in cotinine level between 
peridontitis and healthy individuals is similar among current smokers and nonsmokers.  
While cotinine in all three smoking groups did not meet the 0.01 significance criteria in 
survey weighted regression models, its effect size was still large among smokers 
([a]OR=1.94), and intermediate among former smokers ([a]OR=1.39). 
In this study, blood Pb (PbB) is consistently identified as a risk factor in current and 
former smokers.  Environmental Lead exposures, which are commonly found in developing 
countries and industrialized areas (Tong et al., 2000), have been noted to affect bone 
remodeling and metabolism, and could lead to bone loss and periodontal problems (Arora 
et al., 2009; Dye et al., 2002; Saraiva et al., 2007).  Using the third NHANES data, Saraiva et 
al. (2007) showed that periodontal prevalence rates were higher for both men and women 
with high PbB levels (>7μg/dL) compared to those with low PbB levels (<3μg/dL).  
Additionally, PbB levels also have an affinity for smoking.  Studies have shown that PbB 
levels were significantly elevated in smokers compared to nonsmokers (Mannino et al., 
2003; Mortada et al., 2004).  In a population-based Aging Study of men, Hu et al. (1998) 
demonstrated that bone Lead concentration was associated with age and smoking, which 
were directly related to increases in PbB levels.  PbB levels were not only an indicator of 
current environmental exposures but also past lead exposure that took place years ago 
(Rabinowitz 1998; Hu (Hu et al., 1998). 
In addition to PbB, Antimony is another toxic heavy metal that has been identified as 
a risk factor among nonsmokers.  While previous studies have shown that Antimony may be 
released from dental amalgam particles (Imbeau, 2007), an alloy with mixed metals used 
58 
 
for dental fillings, its relation with human periodontal health is not clear.  The results of this 
study show that Antimony is not only a significant risk factor but also an important 
classifier for periodontitis.  In fact, within the group of nonsmokers, the individuals with the 
highest prevalence of periodontitis are those who are non-White, aged more than 29 and 
have standardized-log Antimony level of more than 0.705 (Figure 4-2c).  
Several nutrients were also found to be associated with periodontitis.  In the 
stratified analysis, cis-b-carotene was found to be protective among nonsmokers; retinyl 
stearate, known as vitamin A stearate, was associated with higher likelihood of 
periodontitis among current smokers.  Cis-b-carotene is an antioxidant nutrient (Paiva and 
Russell, 1999).  Since periodontal diseases are associated with an imbalanced production of 
reactive oxidant species that damage gum tissues (Saini, 2011), antioxidants nutrients such 
as ascorbic acid, beta-carotene, and alpha-tocopherol can act as “buffers” that protect 
against periodontitis (Åsman et al., 1994; Cohen and Meyer, 1993; Nishida et al., 2000; Saini, 
2011).  However, no studies have yet done to examine the relationship between vitamin A 
stearate and periodontitis.  
Several polychlorinated biphenyl (PCBs) were found to increase the odds of 
periodontitis when considered individually but none were selected as important using 
random forests.  Previous knowledge on the relationships between PCBs and periodontitis 
is limited to animal studies with inconsistent results (Hashiguchi et al., 1991; Schandorff, 
1997).  Upon further investigation, however, we found that when dioxins (TCDD and OCDD) 
were included in multiple variable models, the effect of PCB was “wiped-out.”  TCDD is a 
toxic contaminant produced during the preparations of chlorinated phenols (Beatty and 
Neal, 1978) and is known as the most toxic man-made chemical (IARC Working Group on 
the Evaluation of Carcinogenic Risks to Humans, 1997), while OCDD is a specific persistent 
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organic pollutant (POP) and both have been showed to increase the risks of type II diabetes 
(Lee et al., 2007; Lee et al., 2006; Longnecker and Michalek, 2000).  Additionally, Ogawa et 
al. (2003) suggested that OCDD may significantly induce Porphyromonas gingivalis 
production (a pathogenic factor in periodontal diseases) and may be a risk factor for 
periodontal diseases.  Therefore, it is plausible that the absence of PCBs in the variable 
selection by random forests was because the effects of PCBs were out-competed by other 
dominating factors when considering all environmental variables simultaneously rather 
than individually. 
Noticeably, two phthalates (i.e. mono-n-methyl phthalate and mono-n-octyl 
phthalate) were both found to be associated with periodontitis among smokers.  Phthalates, 
known as plasticizers, are widely used in consumer goods as a vinyl softener (Benning et al., 
2013).  They have been shown to associate with various adverse health outcomes, and 
increase serum markers of inflammation and oxidative stress in US general population 
(Ferguson et al., 2011).  In this study, phthalates appear to affect all population but most 
remarkably in current smokers (Table 4-3).  The CART diagram for smokers suggests that 
those who have a lower blood Lead level (standardized-log Lead <0.556) and younger than 
35 have slightly higher (unadjusted) prevalence rate of periodontitis if their standardized-
log phthalate level is higher than 0.081 (9.0%) than those with 0.081 or lower (3.3%) 
(Figure 4-2a).  Among former smokers, individuals whose race is White or “other” have the 
lowest prevalence of periodontitis if their standardized-log phthalate level is less than 0.953 
(unadjusted prevalence=1.9%). 
In two of the three classification tree plots, the first classifying variable was race of 
White vs. Mexican American/Other Hispanics/Black.  This is consistent with previous 
evidence that Mexican American have the highest prevalence of periodontitis compared to 
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other races (Eke et al., 2012), and that race is a dominating factor of the disease (Albandar 
et al., 1999).  In addition, former smokers who were Mexican American, other Hispanics or 
Black and had high PbB level (i.e. standardized-log PbB>0.356) were more likely to have 
periodontitis compared to those with lower level (Figure 4-2b).  Conversely, nonsmokers 
who were non-White and aged over 29 were also more likely to have periodontitis (Figure 
4-2c), although the prevalence was not as high as when both risk factors (i.e. non-White and 
high PbB level) were present among former smokers.  Classification tree diagrams have 
demonstrated that the combination of smoking and race have an indispensible influence 
determining periodontitis status.  
It is interesting to note that race does not appear in the classification tree among 
smokers in Figure 4-2a.  However, previous studies have shown that the association of race 
with periodontitis can be significantly reduced when certain competing effects such as 
smoking and economic status were accounted for (Hyman and Reid, 2003).  In addition, 
while studies have shown that genetic predisposition is significantly related to periodontal 
disease (Albandar, 2002; Haubek et al., 2002), racial characteristics are likely to be 
confounded by socioeconomic and behavioral factors (Hatem).  This explains the 
observation that former smokers who were White would still have high disease prevalence 
if their socioeconomic status is lower than 1.79 (Figure 4-2b). 
The major limitation of the NHANES data was that the same set of environmental 
variable was not collected in each cohort.  This is problematic in conventional regression 
models because an observation with a missing value in any of the explanatory variable 
would be omitted in the model.  Therefore, when fitting potential interactions identified by 
random forests in a logistic regression model, the number of observations was reduced 
dramatically (due to missing values) and led to insignificant results.  Additionally, 
61 
 
periodontal measurements were not consistent throughout the two-year cohorts included 
in this study.  In NHANES 1999-2000, two sites per tooth (mid-facial and mesio-facial) were 
measured; whereas in 2001-2002 and 2003-2004, three sites per tooth (mid-facial, mesio-
facial and distal) were used.  To achieve consistency, periodontal cases were defined using 
two sites per tooth (mid-facial and mesio-facial), which may underestimate the true 
prevalence of periodontitis.  
Other limitation includes that all of the information in NHANSE was collected by 
means of a cross-sectional design.  Therefore, the associations found in this study do not 
imply causality.  Further validation studies using larger longitudinal data sets are needed to 
reconfirm our model.  Some of the important risk factors such as oral hygiene for 
periodontitis were not captured in this dataset.  Studies have suggested that good oral 
hygiene practices including tooth brushing and the use of dental floss that removes 
bacterial plaque from the teeth are fundamental preventive strategies for oral and gum 
diseases (Hamissi, 2012; Pihlstrom et al., 2005).  While studies have shown that preventive 
strategies such as good dental care habits and adequate nutrients may only have limited 
effects on improving periodontal health in the presence of dominating risk factors 
(Merchant et al., 2002), future studies on the interactive effects of preventive oral health 
practices are merited. 
Conclusion  
In addition to the ability to identify well-documented risk factors, random forests 
provide novel findings to correlate environmental exposures to periodontal disease.  
Further analysis using CART as a risk group classifier provides additional complex 
interactive effects between environmental stressors and demographics variables that are 
valuable to consider for future applications. 
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Table 4-1. Demographic information by smoking status 
 All None Current Former 
Percent  53.5% 23.2% 23.3% 
Gender (% male) 48.8% 43.0% 55.3% 55.2% 
Race (%)      
Mexican American 8.0% 8.6% 7.5% 6.5% 
Other Hispanic 5.7% 5.9% 5.8% 5.0% 
Non-Hispanic White 71.0% 68.4% 70.5% 79.5% 
Non-Hispanic Black 10.3% 11.8% 11.2% 5.6% 
Other Race – Including 
Multi-Racial 
5.0% 5.3% 5.0% 3.4% 
Age (%)     
18-30 27.9% 26.1% 33.5% 12.0% 
31-49 43.2% 45.3% 49.8% 40.2% 
50-64 19.0% 17.6% 14.7% 30.3% 
65+ 9.9% 11.0% 2.0% 17.4% 
Age (mean, se) 41.7 (0.3) 42.3 (0.4) 37.4 (0.3) 49.3 (0.4) 
Estimated Social 
Economic Status (median, 
stderr) 
3.2 (0.1) 3.4 (0.1) 2.3 (0.1) 3.9 (0.1) 
Total Teeth (mean, se) 26.2 (0.1) 26.5 (0.1) 25.9 (0.1) 25.5 (0.1) 
Note: The estimates presented in this table are survey-weighted and stratified by the three 
smoking groups. 
 
Table 4-2. Demographic information by periodontitis status 
 All No 
Periodontitis 
Periodontitis P-value 
N (Raw Estimate) 10278 9308 970  
Gender (% male) 48% 48% 62% <.0001 
Race (%)     <.0001 
Mexican American 8.0% 7.7% 12.8%  
Other Hispanic 5.8% 5.4% 10.5%  
Non-Hispanic White 71.0% 72.5% 50.5%  
Non-Hispanic Black 10.3% 9.6% 20.1%  
Other Race – Including 
Multi-Racial 
5.0% 4.9% 6.0%  
Age (%)    <.0001 
18-30 27.9% 29.2% 10.8%  
31-49 43.2% 42.4% 52.3%  
50-64 19.0% 18.5% 25.3%  
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Table 4-2 (Continued) 
65+ 9.9% 9.8% 11.6%  
Age (mean, se) 41.7 (0.30) 41.4 (0.32) 46.3 (0.52) <.0001 
Smoking Status    <.0001 
Non Smoker 53.5% 54.7% 38.7%  
Current Smoker 23.2% 22.0% 39.4%  
Former Smoker 23.3% 23.3% 22.0%  
Estimated Social 
Economic Status 
(median, stderr) 
3.07 (0.05) 3.11 (0.05) 2.48 (0.09) <.0001 
Total Teeth (mean, se) 26.2 (0.05) 26.3 (0.05) 25.1 (0.17) <.0001 
Note: The means and percentages are survey-weighted and stratified by the periodontitis 
status. 
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Table 4-3. Results and summary of the three methodologies classified by smoking status 
  
Current Smokers Former Smokers Nonsmokers 
  
p-
value 
R
F OR 95% CI 
p-
value RF OR 95% CI 
p-
value 
R
F OR 95% CI 
Age 
Demographi
c na √ 
 
na √ 
 
na √ 
 
Race 
Demographi
c na √ 
 
na √ 
 
na √ 
 
Gender 
Demographi
c na 
  
na √ 
 
na √ 
 
SES 
Demographi
c na √ 
 
na √ 
 
na 
  
Total teeth 
Demographi
c na √ 
 
na 
  
na 
  Acrylamide 
(pmoL/G Hb) Acrylamide  
0.066
9 
 
1.39 (1.03-
1.86) 
0.000
9 
 
0.3 (0.2-
0.46) 
0.269
6 
 
0.79 (0.55-
1.16) 
Cotinine 
(ng/mL) Cotinine 
0.020
2 
 
1.94 (1.14-
3.31) 
0.013
6 √ 
1.39 (1.08-
1.77) 
0.088
2 
 
1.2 (0.98-
1.46) 
Cadmium 
(ug/L) heavy metal 
0.005
3 
 
1.31 (1.09-
1.56) 
0.120
4 
 
1.28 (0.94-
1.74) 
0.054
7 
 
1.23 (1-1.5) 
Lead (ug/dL) heavy metal 
0.000
2 √ 
1.48 (1.23-
1.78) 
0.000
1 √ 
1.57 (1.28-
1.93) 
0.001
4 
 
1.34 (1.13-
1.57) 
a-
Tocopherol(u
g/dL) Nutrient 
0.304
3 
 
1.09 (0.92-
1.29) 
0.041
5 √ 
0.75 (0.58-
0.98) 
0.160
3 
 
0.87 (0.72-
1.05) 
cis-b-
carotene(ug/
dL) Nutrient 
0.328
1 
 
0.92 (0.79-
1.08) 
0.893
9 
 
1.02 (0.76-
1.38) 
0.007
4 √ 
0.79 (0.68-
0.92) 
Folate, RBC 
(ng/mL RBC) Nutrient 
0.879
0 
 
1.01 (0.85-
1.21) 
0.100
1 √ 
0.82 (0.65-
1.03) 
0.084
5 
 
0.87 (0.74-
1.02) 
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Table 4-3 (Continued) 
Retinyl 
stearate(ug/d
L) Nutrient 
0.005
7 √ 
1.31 (1.1-
1.57) 
0.077
6 
 
1.22 (0.98-
1.5) 
0.429
5 
 
1.06 (0.91-
1.24) 
Antimony, 
urine 
(ng/mL) heavy metal 
0.257
0 
 
0.85 (0.65-
1.12) 
0.039
9 
 
1.36 (1.03-
1.81) 
0.000
0 √ 
1.49 (1.27-
1.74) 
Dieldrin 
(ng/g) 
pesticides 
organochlor
ine 
0.037
6 
 
0.45 (0.22-
0.91) 
0.007
2 
 
2.21 (1.31-
3.75) 
0.109
6 
 
1.45 (0.94-
2.23) 
Mono-
cyclohexyl 
phthalate phthalates 
0.082
9 √ 
1.34 (0.97-
1.84) 
0.050
2 
 
1.46 (1.01-
2.09) 
0.009
6 
 
1.34 (1.09-
1.64) 
Mono-n-
methyl 
phthalate phthalates 
0.006
2 √ 
1.49 (1.15-
1.93) 
0.207
9 
 
0.73 (0.46-
1.17) 
0.929
0 
 
0.99 (0.75-
1.29) 
Mono-n-octyl 
phthalate phthalates 
0.007
2 √ 
1.55 (1.15-
2.1) 
0.000
2 
 
1.56 (1.26-
1.92) 
0.063
2 
 
1.25 (1-
1.56) 
Equol 
(ng/mL) 
phytoestrog
ens 
0.009
6 
 
1.49 (1.12-
1.98) 
0.641
9 
 
1.1 (0.75-
1.6) 
0.705
4 
 
1.06 (0.79-
1.42) 
Diethylphosp
hate (ug/L) diakyl 
0.035
3 
 
0.78 (0.63-
0.97) 
0.078
0 
 
0.75 (0.55-
1.02) 
0.002
8 
 
1.5 (1.17-
1.91) 
1,2,3,4,6,7,8,9
-ocdd (fg/g) dioxins 
0.276
8 
 
1.19 (0.88-
1.6) 
0.793
5 
 
1.09 (0.56-
2.14) 
0.005
7 
 
1.49 (1.14-
1.95) 
1,2,3,7,8-
pncdd (fg/g) dioxins 
0.009
5 
 
1.6 (1.14-
2.25) 
0.918
7 
 
1.02 (0.68-
1.53) 
0.966
8 
 
0.99 (0.76-
1.31) 
2,3,7,8-tcdd 
(fg/g) dioxins 
0.006
8 
 
1.76 (1.2-
2.58) 
0.024
0 
 
1.57 (1.08-
2.29) 
0.069
3 
 
1.19 (0.99-
1.43) 
PCB105 
(ng/g) pcb 
0.004
2 
 
1.55 (1.17-
2.06) 
0.000
1 
 
1.97 (1.46-
2.65) 
0.008
5 
 
1.34 (1.09-
1.65) 
 6
6
 
 
 
Table 4-3 (Continued) 
PCB146 
(ng/g) pcb 
0.007
3 
 
1.63 (1.16-
2.28) 
0.009
9 
 
2.02 (1.22-
3.36) 
0.352
3 
 
1.18 (0.83-
1.68) 
PCB157 
(ng/g) pcb 
0.014
4 
 
2.04 (1.19-
3.5) 
0.000
4 
 
5.52 (2.33-
13.06) 
0.008
9 
 
1.63 (1.15-
2.3) 
PCB170 
(ng/g) pcb 
0.004
4 
 
1.85 (1.25-
2.75) 
0.353
1 
 
1.42 (0.68-
2.97) 
0.407
9 
 
1.15 (0.83-
1.6) 
PCB172 
(ng/g) pcb 
0.001
7 
 
2.29 (1.42-
3.68) 
0.000
2 
 
5.03 (2.33-
10.85) 
0.018
1 
 
1.57 (1.1-
2.23) 
PCB177 
(ng/g) pcb 
0.002
5 
 
2.01 (1.32-
3.06) 
0.000
3 
 
3.3 (1.83-
5.95) 
0.005
5 
 
1.64 (1.18-
2.27) 
PCB178 
(ng/g) pcb 
0.001
8 
 
2.42 (1.45-
4.04) 
0.000
4 
 
3.13 (1.78-
5.52) 
0.016
8 
 
1.5 (1.09-
2.05) 
PCB183 
(ng/g) pcb 
0.000
3 
 
2.13 (1.47-
3.09) 
0.004
1 
 
2.17 (1.32-
3.57) 
0.017
6 
 
1.45 (1.08-
1.94) 
PCB199 
(ng/g) pcb 
0.040
1 
 
2.25 (1.09-
4.68) 
0.156
1 
 
2 (0.79-
5.07) 
0.080
5 
 
1.28 (0.98-
1.66) 
PCB206 
(ng/g) Pcb 
0.000
6 
 
3.41 (1.86-
6.24) 
0.007
6 
 
5.73 (1.79-
18.34) 
0.009
3 
 
1.85 (1.21-
2.83) 
PCB28 (ng/g) Pcb 
0.964
6 
 
0.99 (0.57-
1.72) 
0.007
2 
 
2 (1.27-
3.15) 
0.013
8 
 
1.65 (1.14-
2.38) 
PCB66 (ng/g) Pcb 
0.012
8 
 
1.54 (1.12-
2.14) 
0.000
1 
 
1.89 (1.44-
2.48) 
0.140
0 
 
1.22 (0.94-
1.57) 
Metolachlor 
mercapturate 
result 
pesticides 
chloroaceta
nilide 
0.000
0 
 
0.03 (0.02-
0.04) 
0.000
0 
 
0.02 (0.01-
0.03) 
0.591
3 
 
1.09 (0.81-
1.48) 
Note:  
(1) The p-values are calculated based on the survey weighted logistic regression with dichotomous periodontitis status as the outcome 
adjusting for age, gender, ethnicity, socioeconomic status and number of teeth.  
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(2) The cells with a check mark (√) indicate the “significant” variable (p<0.01) chosen by the model.  
(3) The variables presented in this table are a subset of the complete list of environmental variables examined. They reflected the variables that 
were selected by at least one of the model. 
(4) The highlighted checks reflect the variables that showed up in the classification regression tree analysis. 
(5) The p-value of 0.01 is determined based on the overall FDR of 5%. A significance of 0.01 corresponds to a FDR of 8%, 10%, and 13% for the 
current, former, and non-smokers, respectively. 
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Figure 4-1 (a-d). Random forest plots for the processed variables  
4-1a) Smokers 
 
4-1b) Former Smokers 
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4-1c) Nonsmokers 
 
4-1d) All three smoking groups 
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Figure 4-2a. CART plot with variables selected by random forest for current smokers 
 
Figure 4-2b. CART plot with variables selected by random forest for former smokers 
 
Figure 4-2c. CART plot with variables selected by random forest for nonsmokers 
71 
 
Supporting Material 
 
Table S-1. NHANES environmental variables categorization by the year data was collected 
 
1999-2000 2001-2002 2003-2004 
Acrylamide 0 0 2 
Cotinine 1 1 1 
Diakyl 6 6 6 
Dioxins 6 7 7 
Furans 6 6 6 
Heavy Metals 14 16 18 
Hydrocarbons 0 8 10 
Nutrients 10 17 18 
Phytoestrogens 6 6 6 
Organochlorine 
Pesticides 9 10 11 
Polychlorinated 
Biphenyls 23 26 27 
Other Pesticides 1 3 8 
Phenols 0 0 3 
Phthalates 7 12 12 
Volatile Compounds 18 20 21 
Total 107 138 156 
 
Table S-2. The complete list of NHANES environment variables and classification 
Classification Environment factors Variable Name 
Demographics Age RIDAGEYR 
Demographics Race RIDRETH1 
Demographics Gender RIAGENDR 
Demographics 
Socio-economic status (measured by 
income poverty ratio) 
INDFMPIR 
Acrylamide  Acrylamide (pmoL/G Hb) LBXACR 
Acrylamide  Glycidamide (pmoL/G Hb) LBXGLY 
Cotinine Cotinine (ng/mL) LBXCOT 
Diakyl Diethyldithiophosphate (ug/L) URXOP6 
Diakyl Diethylphosphate (ug/L) URXOP2 
Diakyl Diethylthiophosphate (ug/L) URXOP4 
Diakyl Dimethyldithiophosphate (ug/L) URXOP5 
Diakyl Dimethylphosphate (ug/L) URXOP1 
Diakyl Dimethylthiophosphate (ug/L) URXOP3 
dioxins 1,2,3,4,6,7,8,9-ocdd (fg/g) LBXD07 
dioxins 1,2,3,4,6,7,8-hpcdd (fg/g) LBXD05 
dioxins 1,2,3,4,7,8-hxcdd (fg/g) LBXD02 
dioxins 1,2,3,6,7,8-hxcdd (fg/g) LBXD03 
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Table S-2 (Continued) 
dioxins 1,2,3,7,8,9-hxcdd (fg/g) LBXD04 
dioxins 1,2,3,7,8-pncdd (fg/g) LBXD01 
dioxins 2,3,7,8-tcdd (fg/g) LBXTCD 
furans dibenzofuran 1,2,3,4,6,7,8-hpcdf (fg/g) LBXF08 
furans dibenzofuran 1,2,3,4,7,8-hxcdf (fg/g) LBXF04 
furans dibenzofuran 1,2,3,6,7,8-hxcdf (fg/g) LBXF05 
furans dibenzofuran 1,2,3,7,8-pncdd (fg/g) LBXD01 
furans dibenzofuran 2,3,4,6,7,8-hxcdf (fg/g) LBXF07 
furans dibenzofuran 2,3,4,7,8-pncdf (fg/g) LBXF03 
heavy metal Cadmium (ug/L) LBXBCD 
heavy metal Lead (ug/dL) LBXBPB 
heavy metal Mercury, inorganic (ug/L) LBXIHG 
heavy metal Mercury, total (ug/L) LBXTHG 
heavy metal Antimony, urine (ng/mL) URXUSB 
heavy metal Barium, urine (ng/mL) URXUBA 
heavy metal Cadmium, urine (ng/mL) URDUCD 
heavy metal Cesium, urine (ng/mL) URXUCS 
heavy metal Cobalt, urine (ng/mL) URXUCO 
heavy metal Lead, urine (ng/mL) URXUPB 
heavy metal Mercury, urine (ng/mL) URXUHG 
heavy metal Molybdenum, urine (ng/mL) URXUMO 
heavy metal Thallium, urine (ng/mL) URXUTL 
heavy metal Tungsten, urine (ng/mL) URXUTU 
heavy metal Uranium, urine (ng/mL) URXUUR 
heavy metal Urinary Dimethylarsonic acid (ug/L) URXUDMA 
heavy metal 
Urinary Monomethylacrsonic acid 
(ug/L) URXUMMA 
heavy metals Iodine, urine (ng/mL) URXUIO 
hydrocarbons 1-napthol (ng/L) URXP01 
hydrocarbons 1-phenanthrene (ng/L) URXP06 
hydrocarbons 1-pyrene (ng/L) URXP10 
hydrocarbons 2-fluorene (ng/L) URXP04 
hydrocarbons 2-napthol (ng/L) URXP02 
hydrocarbons 2-phenanthrene (ng/L) URXP07 
hydrocarbons 3-fluorene (ng/L) URXP03 
hydrocarbons 3-phenanthrene (ng/L) URXP05 
hydrocarbons 4-phenanthrene (ng/L) URXP19 
hydrocarbons 9-fluorene (ng/L) URXP17 
Nutrient a-Carotene(ug/dL) LBXALC 
Nutrient a-Tocopherol(ug/dL) LBXATC 
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Table S-2 (Continued) 
Nutrient b-cryptoxanthin(ug/dL) LBXCRY 
Nutrient cis-b-carotene(ug/dL) LBXCBC 
Nutrient Combined Lutein/zeaxanthin (ug/dL) LBXLUZ 
Nutrient Folate, RBC (ng/mL RBC) LBXRBF 
Nutrient Folate, serum (ng/mL) LBXFOL 
Nutrient g-tocopherol(ug/dL) LBXGTC 
Nutrient Iron, Frozen Serum (ug/dL) LBXIRN 
Nutrient Methylmalonic acid (umol/L) LBXMMA 
Nutrient Retinol(ug/dL) LBXVIA 
Nutrient Retinyl palmitate(ug/dL) LBXRPL 
Nutrient Retinyl stearate(ug/dL) LBXRST 
Nutrient Selenium(ug/L) LBXSEL 
Nutrient trans-b-carotene(ug/dL) LBXBEC 
Nutrient trans-lycopene(ug/dL) LBXLYC 
Nutrient Vitamin B12, serum (pg/mL) LBXB12 
Nutrient Vitamin D (ng/mL) LBDVID 
pcb PCB101 (ng/g) LBX101 
pcb PCB105 (ng/g) LBX105 
pcb PCB118 (ng/g) LBX118 
pcb PCB138 & 158 (ng/g) LBX138 
pcb PCB146 (ng/g) LBX146 
pcb PCB153 (ng/g) LBX153 
pcb PCB156 (ng/g) LBX156 
pcb PCB157 (ng/g) LBX157 
pcb PCB167 (ng/g) LBX167 
pcb PCB170 (ng/g) LBX170 
pcb PCB172 (ng/g) LBX172 
pcb PCB177 (ng/g) LBX177 
pcb PCB178 (ng/g) LBX178 
pcb PCB180 (ng/g) LBX180 
pcb PCB183 (ng/g) LBX183 
pcb PCB187 (ng/g) LBX187 
pcb PCB194 (ng/g) LBX194 
pcb PCB196 & 203 (ng/g) LBX196 
pcb PCB199 (ng/g) LBD199 
pcb PCB206 (ng/g) LBX206 
pcb PCB28 (ng/g) LBX028 
pcb PCB52 (ng/g) LBX052 
pcb PCB66 (ng/g) LBX066 
pcb PCB74 (ng/g) LBX074 
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Table S-2 (Continued) 
pcb PCB99 (ng/g) LBX099 
pcbs 3,3',4,4',5,5'-hxcb (fg/g) LBXHXC 
pcbs 3,3',4,4',5-pncb (fg/g) LBXPCB 
pesticides 
chloroacetanilide Metolachlor mercapturate result 
URXMET 
pesticides organochlorine Beta-hexachlorocyclohexane (ng/g) LBXBHC 
pesticides organochlorine Dieldrin (ng/g) LBXDIE 
pesticides organochlorine Heptachlor Epoxide (ng/g) LBXHPE 
pesticides organochlorine Hexachlorobenzene (ng/g) LBXHCB 
pesticides organochlorine Mirex (ng/g) LBXMIR 
pesticides organochlorine o,p'-DDT (ng/g) LBXODT 
pesticides organochlorine Oxychlordane (ng/g) LBXOXY 
pesticides organochlorine p,p'-DDE (ng/g) LBXPDE 
pesticides organochlorine p,p'-DDT (ng/g) LBXPDT 
pesticides organochlorine Trans-nonachlor (ng/g) LBXTNA 
pesticides 
organophosphate diethylaminomethylpyrimidinol/one 
URXDPY 
pesticides phenols 2,4,5-trichlorophenol (ug/L) result URX1TB 
pesticides phenols 2,4,6-trichlorophenol (ug/L) result URX3TB 
pesticides phenols 2,4-dichlorophenol (ug/L) result URXDCB 
pesticides phenols 2,5-dichlorophenol (ug/L) result URX14D 
pesticides phenols O-Phenyl phenol (ug/L) result URXOPP 
pesticides phenols Pentachlorophenol (ug/L) URXPCP 
pesticides pyrethyroid dichlorovnl-dimeth prop carboacid URXTCC 
phenols Urinary 4-tert-octyl phenol (ng/mL) URX4TO 
phenols Urinary Benzophenone-3 (ng/mL) URXBP3 
phenols Urinary Bisphenol A (ng/mL) URXBPH 
phthalates Mono-(2-ethyl)-hexyl phthalate URXMHP 
phthalates 
Mono-(2-ethyl-5-hydroxyhexyl) 
phthalate URXMHH 
phthalates Mono-(2-ethyl-5-oxohexl) phthalate URXMOH 
phthalates Mono-(3-carboxypropyl) phthalate URXMC1 
phthalates Mono-benzyl phthalate URXMZP 
phthalates Mono-cyclohexyl phthalate URXMCP 
phthalates Mono-ethyl phthalate URXMEP 
phthalates Mono-isobutyl phthalate URXMIB 
phthalates Mono-isononyl phthalate URXMNP 
phthalates Mono-n-butyl phthalate URXMBP 
phthalates Mono-n-methyl phthalate URXMNM 
phthalates Mono-n-octyl phthalate URXMOP 
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Table S-2 (Continued) 
phytoestrogens Daidzein (ng/mL) URXDAZ 
phytoestrogens Enterodiol (ng/mL) URXETD 
phytoestrogens Enterolactone (ng/mL) URXETL 
phytoestrogens Equol (ng/mL) URXEQU 
phytoestrogens Genistein (ng/mL) URXGNS 
phytoestrogens 
o-Desmethylangolensin (O-DMA) 
(ng/mL) URXDMA 
volatile compounds Blood 1,1,1-Trichloroethane (ng/mL) LBXV3A 
volatile compounds Blood 1,4-Dichlorobenzene (ng/mL) LBXVDB 
volatile compounds Blood Benzene (ng/mL) LBXVBZ 
volatile compounds Blood Bromodichloromethane (pg/mL) LBXVBM 
volatile compounds Blood Bromoform (pg/mL) LBXVBF 
volatile compounds Blood Carbon Tetrachloride (ng/mL) LBXVCT 
volatile compounds Blood Chloroform (pg/mL) LBXVCF 
volatile compounds Blood Dibromochloromethane (pg/mL) LBXVCM 
volatile compounds Blood Ethylbenzene (ng/mL) LBXVEB 
volatile compounds Blood m-/p-Xylene (ng/mL) LBXVXY 
volatile compounds Blood MTBE (pg/mL) LBXVME 
volatile compounds Blood o-Xylene (ng/mL) LBXVOX 
volatile compounds Blood Styrene (ng/mL) LBXVST 
volatile compounds Blood Tetrachloroethene (ng/mL) LBXV4C 
volatile compounds Blood Toluene (ng/mL) LBXVTO 
volatile compounds Blood Trichloroethene (ng/mL) LBXVTC 
volatile compounds Water Bromodichloromethane (ng/mL) LBXWBM 
volatile compounds Water Bromoform (ng/mL) LBXWBF 
volatile compounds Water Chloroform (ng/mL) LBXWCF 
volatile compounds Water Dibromochloromethane (ng/mL) LBXWCM 
volatile compounds Water MTBE (ng/mL) LBXWME 
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Table S-3: Complete list of environmental variables and the parameter estimates from survey-weighted logistic regressions 
  
Estimate SE t p p<0.01 
Acrylamide (pmoL/G Hb) Acrylamide  0.331461 0.1222 2.712445 0.030092 
 
Glycidamide (pmoL/G Hb) Acrylamide  0.309717 0.151089 2.049895 0.079543 
 Cotinine (ng/mL) Cotinine 0.439774 0.057071 7.705671 3.99E-09 √ 
Cadmium (ug/L) heavy metal 0.416961 0.044007 9.474824 2.57E-11 √ 
Lead (ug/dL) heavy metal 0.473522 0.062083 7.627253 5.03E-09 √ 
Mercury, inorganic (ug/L) heavy metal -0.41017 0.153304 -2.67554 0.011156 
 Mercury, total (ug/L) heavy metal -0.15746 0.097935 -1.60778 0.11662 
 a-Carotene(ug/dL) Nutrient -0.19674 0.07469 -2.63413 0.015153 
 a-Tocopherol(ug/dL) Nutrient -0.10066 0.052795 -1.90671 0.064565 
 b-cryptoxanthin(ug/dL) Nutrient -0.17402 0.059468 -2.92627 0.007819 √ 
cis-b-carotene(ug/dL) Nutrient -0.23455 0.07005 -3.34829 0.002908 √ 
Combined Lutein/zeaxanthin 
(ug/dL) Nutrient -0.11025 0.065104 -1.69338 0.104498 
 Folate, RBC (ng/mL RBC) Nutrient -0.18279 0.053393 -3.42357 0.001557 √ 
Folate, serum (ng/mL) Nutrient -0.22899 0.060788 -3.76699 0.000592 √ 
g-tocopherol(ug/dL) Nutrient 0.145617 0.048781 2.98512 0.005071 √ 
Iron, Frozen Serum (ug/dL) Nutrient 0.012892 0.050175 0.25694 0.798688 
 Methylmalonic acid (umol/L) Nutrient -0.05588 0.075273 -0.74235 0.462692 
 Retinol(ug/dL) Nutrient -0.01641 0.047151 -0.34793 0.729919 
 Retinyl palmitate(ug/dL) Nutrient 0.094333 0.062913 1.499431 0.142481 
 Retinyl stearate(ug/dL) Nutrient 0.159909 0.052686 3.03515 0.004447 √ 
Selenium(ug/L) Nutrient -0.01295 0.227366 -0.05694 0.956188 
 trans-b-carotene(ug/dL) Nutrient -0.1956 0.068556 -2.85309 0.009247 √ 
trans-lycopene(ug/dL) Nutrient 0.009168 0.053994 0.169797 0.866721 
 Vitamin B12, serum (pg/mL) Nutrient 0.00732 0.042905 0.170613 0.865483 
 Vitamin D (ng/mL) Nutrient -0.16887 0.135054 -1.25038 0.251338 
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Table S-3 (Continued) 
Antimony, urine (ng/mL) heavy metal 0.224797 0.060353 3.72472 0.000668 √ 
Barium, urine (ng/mL) heavy metal 0.038758 0.090333 0.429058 0.670438 
 Cadmium, urine (ng/mL) heavy metal 0.380694 0.117939 3.227881 0.002659 √ 
Cesium, urine (ng/mL) heavy metal 0.056132 0.082445 0.680835 0.500332 
 Cobalt, urine (ng/mL) heavy metal 0.080603 0.088621 0.909524 0.369123 
 Lead, urine (ng/mL) heavy metal 0.247824 0.088825 2.790021 0.008375 √ 
Mercury, urine (ng/mL) heavy metal -0.03788 0.09492 -0.39903 0.692228 
 Molybdenum, urine (ng/mL) heavy metal 0.028418 0.095933 0.296224 0.768761 
 Thallium, urine (ng/mL) heavy metal 0.04272 0.091857 0.465074 0.64468 
 Tungsten, urine (ng/mL) heavy metal 0.131181 0.092775 1.413976 0.165959 
 Uranium, urine (ng/mL) heavy metal 0.123441 0.085597 1.442113 0.163356 
 Urinary Dimethylarsonic acid (ug/L) heavy metal 0.189999 0.183969 1.032778 0.336064 
 Urinary Monomethylacrsonic acid 
(ug/L) heavy metal 0.238631 0.164124 1.453968 0.189275 
 1-napthol (ng/L) hydrocarbons 0.314344 0.080177 3.920616 0.000732 √ 
1-phenanthrene (ng/L) hydrocarbons 0.307236 0.084096 3.653392 0.001399 √ 
1-pyrene (ng/L) hydrocarbons 0.335703 0.099161 3.385446 0.002662 √ 
2-fluorene (ng/L) hydrocarbons 0.472494 0.085058 5.554957 1.39E-05 √ 
2-napthol (ng/L) hydrocarbons 0.318404 0.08606 3.699768 0.001251 √ 
2-phenanthrene (ng/L) hydrocarbons 0.319017 0.107016 2.981006 0.006891 √ 
3-fluorene (ng/L) hydrocarbons 0.466587 0.094409 4.942163 6.06E-05 √ 
3-phenanthrene (ng/L) hydrocarbons 0.272921 0.084394 3.233887 0.003815 √ 
4-phenanthrene (ng/L) hydrocarbons 0.46557 0.166027 2.804184 0.026365 
 9-fluorene (ng/L) hydrocarbons 0.394369 0.182707 2.158482 0.06776 
 
Beta-hexachlorocyclohexane (ng/g) 
pesticides 
organochlorine 0.132876 0.120332 1.10424 0.276815 
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Table S-3 (Continued) 
Dieldrin (ng/g) 
pesticides 
organochlorine 0.149616 0.141046 1.060762 0.300305 
 
Heptachlor Epoxide (ng/g) 
pesticides 
organochlorine 0.077256 0.106563 0.724978 0.473151 
 
Hexachlorobenzene (ng/g) 
pesticides 
organochlorine 0.06671 0.129771 0.514061 0.610351 
 
Mirex (ng/g) 
pesticides 
organochlorine 0.151425 0.060156 2.517194 0.016422 
 
o,p'-DDT (ng/g) 
pesticides 
organochlorine 0.306361 0.130833 2.341623 0.024852 
 
Oxychlordane (ng/g) 
pesticides 
organochlorine 0.336844 0.144145 2.336839 0.025129 
 
p,p'-DDE (ng/g) 
pesticides 
organochlorine 0.166693 0.104474 1.595549 0.119332 
 
p,p'-DDT (ng/g) 
pesticides 
organochlorine 0.170553 0.090323 1.888264 0.06707 
 
Trans-nonachlor (ng/g) 
pesticides 
organochlorine 0.227543 0.148485 1.532432 0.134158 
 
diethylaminomethylpyrimidinol/one 
pesticides 
organophosphate -0.19328 0.111729 -1.72989 0.12727 
 dichlorovnl-dimeth prop carboacid pesticides pyrethyroid 0.149485 0.065656 2.276805 0.033382 
 Mono-(2-ethyl)-hexyl phthalate phthalates 0.145871 0.078601 1.855829 0.071679 
 Mono-(2-ethyl-5-hydroxyhexyl) 
phthalate phthalates 0.073331 0.082867 0.884915 0.385772 
 Mono-(2-ethyl-5-oxohexl) phthalate phthalates 0.066584 0.084347 0.789402 0.438303 
 Mono-(3-carboxypropyl) phthalate phthalates 0.108596 0.126326 0.859646 0.399255 
 Mono-benzyl phthalate phthalates 0.09121 0.06246 1.460284 0.152885 
 Mono-cyclohexyl phthalate phthalates 0.302634 0.101412 2.984214 0.005083 √ 
Mono-ethyl phthalate phthalates -0.12422 0.080517 -1.5428 0.131626 
 Mono-isobutyl phthalate phthalates 0.009383 0.113464 0.082694 0.934843 
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Table S-3 (Continued) 
Mono-isononyl phthalate phthalates 0.087879 0.04992 1.760412 0.086832 
 Mono-n-butyl phthalate phthalates 0.167679 0.079341 2.113393 0.041565 
 Mono-n-methyl phthalate phthalates 0.036516 0.099624 0.36654 0.717464 
 Mono-n-octyl phthalate phthalates 0.301672 0.079744 3.782999 0.000565 √ 
Daidzein (ng/mL) phytoestrogens -0.04913 0.083386 -0.58917 0.559428 
 Enterodiol (ng/mL) phytoestrogens -0.03513 0.088825 -0.3955 0.694805 
 Enterolactone (ng/mL) phytoestrogens -0.0048 0.109487 -0.04381 0.965295 
 Equol (ng/mL) phytoestrogens 0.19864 0.082451 2.409193 0.021229 
 Genistein (ng/mL) phytoestrogens -0.04797 0.087972 -0.54534 0.588885 
 o-Desmethylangolensin (O-DMA) 
(ng/mL) phytoestrogens 0.012329 0.078064 0.157938 0.875388 
 Diethyldithiophosphate (ug/L) diakyl 0.144674 0.130171 1.11141 0.273759 
 Diethylphosphate (ug/L) diakyl -0.0131 0.074926 -0.17484 0.862183 
 Diethylthiophosphate (ug/L) diakyl 0.007018 0.092248 0.076083 0.939775 
 Dimethyldithiophosphate (ug/L) diakyl 0.038044 0.114347 0.332706 0.741286 
 Dimethylphosphate (ug/L) diakyl -0.12957 0.085292 -1.51919 0.13745 
 Dimethylthiophosphate (ug/L) diakyl -0.12299 0.105532 -1.1654 0.251521 
 1,2,3,4,6,7,8,9-ocdd (fg/g) dioxins 0.192182 0.126266 1.522037 0.136736 
 1,2,3,4,6,7,8-hpcdd (fg/g) dioxins -0.01051 0.162207 -0.0648 0.948689 
 1,2,3,4,7,8-hxcdd (fg/g) dioxins -0.07594 0.12152 -0.62495 0.538433 
 1,2,3,6,7,8-hxcdd (fg/g) dioxins 0.050597 0.187789 0.269434 0.789134 
 1,2,3,7,8,9-hxcdd (fg/g) dioxins 0.124532 0.087012 1.431204 0.160996 
 1,2,3,7,8-pncdd (fg/g) dioxins 0.177441 0.09305 1.906947 0.064532 
 2,3,7,8-tcdd (fg/g) dioxins 0.320643 0.085205 3.763202 0.000598 √ 
1,2,3,4,6,7,8-hpcdf (fg/g) furans dibenzofuran -0.01815 0.126619 -0.14335 0.886817 
 1,2,3,4,7,8-hxcdf (fg/g) furans dibenzofuran 0.14143 0.134978 1.047803 0.301714 
 1,2,3,6,7,8-hxcdf (fg/g) furans dibenzofuran 0.166998 0.124664 1.339592 0.188774 
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Table S-3 (Continued) 
1,2,3,7,8-pncdd (fg/g) furans dibenzofuran 0.177441 0.09305 1.906947 0.064532 
 2,3,4,6,7,8-hxcdf (fg/g) furans dibenzofuran 0.058333 0.082087 0.710628 0.481894 
 2,3,4,7,8-pncdf (fg/g) furans dibenzofuran 0.017993 0.115969 0.155156 0.877565 
 Iodine, urine (ng/mL) heavy metals -0.03848 0.095104 -0.40463 0.689659 
 PCB101 (ng/g) pcb 0.16419 0.103186 1.591197 0.12031 
 PCB105 (ng/g) pcb 0.386874 0.096466 4.010481 0.000292 √ 
PCB118 (ng/g) pcb 0.010228 0.138881 0.073649 0.941698 
 PCB138 & 158 (ng/g) pcb 0.374214 0.126576 2.956433 0.005464 √ 
PCB146 (ng/g) pcb 0.420162 0.1222 3.438309 0.001495 √ 
PCB153 (ng/g) pcb 0.463702 0.134831 3.439126 0.001491 √ 
PCB156 (ng/g) pcb 0.412317 0.147079 2.803383 0.008096 √ 
PCB157 (ng/g) pcb 0.699492 0.170996 4.090687 0.000231 √ 
PCB167 (ng/g) pcb 0.514964 0.147199 3.498411 0.001265 √ 
PCB170 (ng/g) pcb 0.531554 0.135865 3.912364 0.000389 √ 
PCB172 (ng/g) pcb 0.770123 0.153559 5.015167 1.43E-05 √ 
PCB177 (ng/g) pcb 0.679267 0.130713 5.196621 8.23E-06 √ 
PCB178 (ng/g) pcb 0.694141 0.143657 4.831917 2.51E-05 √ 
PCB180 (ng/g) pcb 0.433709 0.152006 2.853244 0.00713 √ 
PCB183 (ng/g) pcb 0.610999 0.107401 5.688929 1.81E-06 √ 
PCB187 (ng/g) pcb 0.442484 0.124425 3.556243 0.001076 √ 
PCB194 (ng/g) pcb 0.636046 0.19752 3.220156 0.00394 √ 
PCB196 & 203 (ng/g) pcb 0.549193 0.178061 3.084297 0.00542 √ 
PCB199 (ng/g) pcb 0.694105 0.20664 3.359005 0.002835 √ 
PCB206 (ng/g) pcb 0.966984 0.172723 5.598467 1.25E-05 √ 
PCB28 (ng/g) pcb 0.273599 0.168865 1.620222 0.120105 
 PCB52 (ng/g) pcb 0.275676 0.120389 2.289879 0.027995 
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Table S-3 (Continued) 
PCB66 (ng/g) pcb 0.35722 0.094155 3.793972 0.000547 √ 
PCB74 (ng/g) pcb 0.096795 0.134187 0.72134 0.47536 
 PCB99 (ng/g) pcb 0.272934 0.092417 2.953285 0.005509 √ 
3,3',4,4',5,5'-hxcb (fg/g) pcbs 0.256466 0.151571 1.692048 0.099276 
 3,3',4,4',5-pncb (fg/g) pcbs -0.12751 0.16237 -0.7853 0.437418 
 
Metolachlor mercapturate result 
pesticides 
chloroacetanilide -0.14659 0.164541 -0.8909 0.402566 
 2,4,5-trichlorophenol (ug/L) result pesticides phenols -0.03614 0.297478 -0.12148 0.906724 
 2,4,6-trichlorophenol (ug/L) result pesticides phenols -0.0554 0.154838 -0.35777 0.731063 
 2,4-dichlorophenol (ug/L) result pesticides phenols -0.16958 0.120154 -1.41134 0.166728 
 2,5-dichlorophenol (ug/L) result pesticides phenols 0.18139 0.260251 0.696982 0.508292 
 O-Phenyl phenol (ug/L) result pesticides phenols -0.08094 0.20244 -0.39984 0.701196 
 Pentachlorophenol (ug/L) pesticides phenols -0.45648 0.206187 -2.21393 0.062434 
 Urinary 4-tert-octyl phenol (ng/mL) phenols -0.39537 0.149079 -2.6521 0.032841 
 Urinary Benzophenone-3 (ng/mL) phenols -0.38346 0.174453 -2.19809 0.063911 
 Urinary Bisphenol A (ng/mL) phenols -0.03791 0.134759 -0.28133 0.786593 
 Blood 1,1,1-Trichloroethane 
(ng/mL) volatile compounds -0.34439 0.238886 -1.44163 0.164155 
 Blood 1,4-Dichlorobenzene (ng/mL) volatile compounds 0.079596 0.10436 0.762709 0.451223 
 Blood Benzene (ng/mL) volatile compounds 0.490723 0.128269 3.825729 0.00057 √ 
Blood Bromodichloromethane 
(pg/mL) volatile compounds 0.095563 0.125309 0.76262 0.451849 
 Blood Bromoform (pg/mL) volatile compounds -0.1304 0.180048 -0.72423 0.474935 
 Blood Carbon Tetrachloride 
(ng/mL) volatile compounds 0.216809 0.086802 2.497732 0.018422 
 Blood Chloroform (pg/mL) volatile compounds -0.03995 0.112596 -0.35485 0.72546 
 Blood Dibromochloromethane  volatile compounds -0.06207 0.117879 -0.52652 0.602533 
 Blood Ethylbenzene (ng/mL) volatile compounds 0.247541 0.120571 2.053079 0.047386 
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Table S-3 (Continued) 
Blood m-/p-Xylene (ng/mL) volatile compounds 0.186347 0.14149 1.317034 0.19615 
 Blood MTBE (pg/mL) volatile compounds 0.081933 0.213513 0.383737 0.704417 
 Blood o-Xylene (ng/mL) volatile compounds 0.201965 0.102025 1.979554 0.055439 
 Blood Styrene (ng/mL) volatile compounds 0.303342 0.107911 2.811031 0.00794 √ 
Blood Tetrachloroethene (ng/mL) volatile compounds -0.01955 0.119815 -0.16317 0.871295 
 Blood Toluene (ng/mL) volatile compounds 0.395883 0.114498 3.45756 0.001417 √ 
Blood Trichloroethene (ng/mL) volatile compounds 0.258359 0.097498 2.649875 0.011887 
  
Table S-4: Complete list of environmental variables and the parameter estimates from survey-weighted logistic regressions 
stratified by smoking groups 
  Current Smoker Former Smoker Nonsmoker 
  estim
ate 
stder
r 
t p estim
ate 
stder
r 
t p estim
ate 
stder
r 
t p 
Acrylamide (pmoL/G 
Hb) 
Acrylamide  0.326
288 
0.150
595 
2.166
657 
0.066
947 
-
1.193 
0.215
243 
-
5.544 
0.000
865 
-
0.229 
0.191
373 
-
1.198 
0.269
559 
Glycidamide (pmoL/G 
Hb) 
Acrylamide  0.484
445 
0.157
802 
3.069
961 
0.018
068 
-
0.458
73 
0.140
377 
-
3.267
82 
0.013
715 
-
0.110
98 
0.178
385 
-
0.622
15 
0.553
56 
Cotinine (ng/mL) Cotinine 0.661
89 
0.272
434 
2.429
545 
0.020
235 
0.326
097 
0.125
734 
2.593
544 
0.013
649 
0.178
477 
0.101
851 
1.752
345 
0.088
229 
Cadmium (ug/L) heavy 
metal 
0.267
558 
0.090
224 
2.965
472 
0.005
337 
0.248
17 
0.155
997 
1.590
869 
0.120
384 
0.203
196 
0.102
34 
1.985
494 
0.054
747 
Lead (ug/dL) heavy 
metal 
0.392
111 
0.094
38 
4.154
586 
0.000
192 
0.451
054 
0.105
122 
4.290
757 
0.000
128 
0.289
56 
0.083
856 
3.453
076 
0.001
435 
Mercury, inorganic 
(ug/L) 
heavy 
metal 
-
0.407
53 
0.341
402 
-
1.193
7 
0.240
402 
-
0.610
09 
0.233
214 
-
2.616
02 
0.013
174 
-
0.315
4 
0.157
802 
-
1.998
72 
0.053
233 
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Table S-4 (Continued) 
Mercury, total (ug/L) heavy 
metal 
0.031
546 
0.149
197 
0.211
44 
0.833
737 
-
0.347
67 
0.241
053 
-
1.442
29 
0.158
371 
-
0.158
9 
0.138
98 
-
1.143
36 
0.260
434 
a-Carotene(ug/dL) Nutrient -
0.025
29 
0.093
743 
-
0.269
8 
0.789
832 
0.004
399 
0.124
829 
0.035
24 
0.972
206 
-
0.127
75 
0.092
734 
-
1.377
65 
0.182
167 
a-Tocopherol(ug/dL) Nutrient 0.089
488 
0.085
876 
1.042
057 
0.304
333 
-
0.286
77 
0.135
657 
-
2.113
93 
0.041
516 
-
0.137
25 
0.095
745 
-
1.433
5 
0.160
344 
b-
cryptoxanthin(ug/dL) 
Nutrient 0.037
861 
0.088
56 
0.427
516 
0.673
159 
-
0.136
42 
0.120
954 
-
1.127
85 
0.271
533 
-
0.140
19 
0.113
405 
-
1.236
19 
0.229
425 
cis-b-carotene(ug/dL) Nutrient -
0.078
87 
0.078
857 
-
1.000
2 
0.328
091 
0.020
712 
0.153
577 
0.134
862 
0.893
947 
-
0.232
67 
0.078
797 
-
2.952
84 
0.007
354 
Combined 
Lutein/zeaxanthin 
(ug/dL) 
Nutrient -
0.004
79 
0.078
88 
-
0.060
73 
0.952
119 
-
0.013
64 
0.141
203 
-
0.096
63 
0.923
899 
-
0.096
09 
0.096
365 
-
0.997
1 
0.329
556 
Folate, RBC (ng/mL 
RBC) 
Nutrient 0.013
898 
0.090
631 
0.153
345 
0.878
982 
-
0.196
1 
0.116
195 
-
1.687
67 
0.100
122 
-
0.143
42 
0.080
847 
-
1.773
94 
0.084
533 
Folate, serum (ng/mL) Nutrient 0.037
046 
0.088
597 
0.418
137 
0.678
331 
-
0.268
09 
0.118
077 
-
2.270
5 
0.029
261 
-
0.242
84 
0.096
089 
-
2.527
19 
0.016
032 
g-tocopherol(ug/dL) Nutrient 0.087
427 
0.079
532 
1.099
27 
0.278
948 
0.132
379 
0.094
602 
1.399
324 
0.170
274 
0.075
208 
0.074
448 
1.010
217 
0.319
133 
Iron, Frozen Serum 
(ug/dL) 
Nutrient -
0.017
61 
0.098
253 
-
0.179
18 
0.858
799 
0.171
083 
0.119
308 
1.433
96 
0.160
213 
-
0.042
78 
0.065
221 
-
0.655
9 
0.516
057 
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Table S-4 (Continued) 
Methylmalonic acid 
(umol/L) 
Nutrient -
0.099
7 
0.140
736 
-
0.708
41 
0.483
254 
-
0.115
2 
0.146
975 
-
0.783
83 
0.438
266 
0.012
545 
0.075
751 
0.165
602 
0.869
396 
Retinol(ug/dL) Nutrient 0.081
62 
0.091
163 
0.895
32 
0.376
564 
0.007
086 
0.094
876 
0.074
688 
0.940
877 
-
0.138
82 
0.092
003 
-
1.508
89 
0.140
054 
Retinyl 
palmitate(ug/dL) 
Nutrient 0.268
679 
0.103
377 
2.599
016 
0.013
468 
-
0.020
8 
0.120
326 
-
0.172
87 
0.863
725 
0.036
656 
0.081
98 
0.447
13 
0.657
46 
Retinyl 
stearate(ug/dL) 
Nutrient 0.270
029 
0.091
421 
2.953
697 
0.005
663 
0.194
927 
0.107
314 
1.816
414 
0.077
641 
0.061
856 
0.077
409 
0.799
077 
0.429
486 
Selenium(ug/L) Nutrient 0.047
767 
0.357
92 
0.133
456 
0.897
588 
0.155
429 
0.352
813 
0.440
542 
0.672
828 
0.182
528 
0.160
026 
1.140
612 
0.291
548 
trans-b-
carotene(ug/dL) 
Nutrient -
0.059
86 
0.076
171 
-
0.785
9 
0.440
309 
0.044
682 
0.139
679 
0.319
891 
0.752
069 
-
0.143
16 
0.088
781 
-
1.612
57 
0.121
093 
trans-lycopene(ug/dL) Nutrient 0.067
8 
0.076
103 
0.890
909 
0.382
618 
0.094
211 
0.083
447 
1.128
99 
0.271
063 
-
0.037
94 
0.099
07 
-
0.382
99 
0.705
401 
Vitamin B12, serum 
(pg/mL) 
Nutrient 0.152
778 
0.074
322 
2.055
625 
0.047
127 
-
0.135
78 
0.110
256 
-
1.231
54 
0.226
106 
0.012
777 
0.068
269 
0.187
151 
0.852
593 
Vitamin D (ng/mL) Nutrient 0.202
644 
0.224
521 
0.902
563 
0.396
752 
-
0.324
83 
0.242
463 
-
1.339
7 
0.222
2 
-
0.349
8 
0.115
004 
-
3.041
64 
0.018
803 
Antimony, urine 
(ng/mL) 
heavy 
metal 
-
0.158
85 
0.137
923 
-
1.151
73 
0.257
024 
0.310
344 
0.145
567 
2.131
961 
0.039
904 
0.396
026 
0.079
667 
4.971
016 
1.64E
-05 
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Table S-4 (Continued) 
Barium, urine (ng/mL) heavy 
metal 
-
0.034
03 
0.173
264 
-
0.196
38 
0.845
414 
0.019
187 
0.136
335 
0.140
735 
0.888
864 
0.178
666 
0.135
802 
1.315
639 
0.196
613 
Cadmium, urine 
(ng/mL) 
heavy 
metal 
0.129
827 
0.213
204 
0.608
933 
0.546
393 
0.358
278 
0.232
044 
1.544
007 
0.131
333 
0.352
705 
0.153
212 
2.302
07 
0.027
224 
Cesium, urine (ng/mL) heavy 
metal 
-
0.047
56 
0.129
74 
-
0.366
58 
0.716
078 
0.092
138 
0.144
757 
0.636
502 
0.528
476 
0.183
689 
0.122
667 
1.497
451 
0.142
994 
Cobalt, urine (ng/mL) heavy 
metal 
-
0.100
65 
0.160
822 
-
0.625
86 
0.535
353 
0.136
707 
0.162
75 
0.839
981 
0.406
463 
0.224
466 
0.132
634 
1.692
369 
0.099
215 
Lead, urine (ng/mL) heavy 
metal 
0.033
483 
0.159
825 
0.209
498 
0.835
241 
0.394
655 
0.171
461 
2.301
724 
0.027
245 
0.262
065 
0.132
421 
1.979
036 
0.055
5 
Mercury, urine 
(ng/mL) 
heavy 
metal 
-
0.364
68 
0.334
333 
-
1.090
76 
0.282
626 
-
0.691
35 
0.299
562 
-
2.307
88 
0.027
22 
0.044
525 
0.234
06 
0.190
229 
0.850
198 
Molybdenum, urine 
(ng/mL) 
heavy 
metal 
0.099
557 
0.153
27 
0.649
551 
0.520
106 
-
0.071
98 
0.140
899 
-
0.510
84 
0.612
583 
0.126
705 
0.116
689 
1.085
837 
0.284
769 
Thallium, urine 
(ng/mL) 
heavy 
metal 
0.030
8 
0.192
365 
0.160
114 
0.873
687 
0.128
823 
0.143
129 
0.900
05 
0.374
075 
0.108
16 
0.147
43 
0.733
636 
0.467
922 
Tungsten, urine 
(ng/mL) 
heavy 
metal 
0.010
506 
0.187
615 
0.055
998 
0.955
653 
0.175
898 
0.167
97 
1.047
194 
0.301
99 
0.191
139 
0.117
497 
1.626
753 
0.112
512 
Uranium, urine 
(ng/mL) 
heavy 
metal 
-
0.039
78 
0.158
016 
-
0.251
74 
0.803
581 
0.244
886 
0.210
407 
1.163
869 
0.256
945 
0.087
34 
0.069
922 
1.249
092 
0.224
759 
Urinary 
Dimethylarsonic acid 
(ug/L) 
heavy 
metal 
0.585
597 
0.324
883 
1.802
486 
0.114
467 
-
0.125
08 
0.311
167 
-
0.401
98 
0.699
687 
0.350
884 
0.265
75 
1.320
354 
0.228
249 
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Table S-4 (Continued) 
Urinary 
Monomethylacrsonic 
acid (ug/L) 
heavy 
metal 
0.604
849 
0.330
243 
1.831
526 
0.109
7 
-
0.110
88 
0.218
46 
-
0.507
55 
0.627
365 
0.425
012 
0.235
704 
1.803
164 
0.114
354 
1-napthol (ng/L) hydrocarb
ons 
0.028
28 
0.225
965 
0.125
15 
0.901
541 
-
0.076
08 
0.264
373 
-
0.287
76 
0.776
221 
0.194
107 
0.139
306 
1.393
382 
0.177
423 
1-phenanthrene 
(ng/L) 
hydrocarb
ons 
0.289
483 
0.155
531 
1.861
259 
0.076
124 
-
0.001
63 
0.250
541 
-
0.006
5 
0.994
868 
0.192
045 
0.121
56 
1.579
835 
0.128
416 
1-pyrene (ng/L) hydrocarb
ons 
0.103
736 
0.129
894 
0.798
619 
0.433
049 
0.254
06 
0.341
76 
0.743
387 
0.465
113 
0.088
262 
0.143
72 
0.614
127 
0.545
431 
2-fluorene (ng/L) hydrocarb
ons 
0.351
93 
0.150
762 
2.334
334 
0.029
11 
0.062
872 
0.251
467 
0.250
022 
0.804
89 
0.179
622 
0.121
505 
1.478
31 
0.153
5 
2-napthol (ng/L) hydrocarb
ons 
0.186
95 
0.174
396 
1.071
983 
0.295
347 
-
0.109
1 
0.242
222 
-
0.450
41 
0.656
821 
-
0.060
76 
0.136
774 
-
0.444
24 
0.661
206 
2-phenanthrene 
(ng/L) 
hydrocarb
ons 
0.212
726 
0.167
499 
1.270
018 
0.217
347 
-
0.053
8 
0.284
372 
-
0.189
19 
0.851
682 
0.218
981 
0.144
667 
1.513
688 
0.144
34 
3-fluorene (ng/L) hydrocarb
ons 
0.274
93 
0.172
299 
1.595
657 
0.124
831 
-
0.159
75 
0.331
402 
-
0.482
04 
0.634
536 
0.272
552 
0.148
109 
1.840
212 
0.079
268 
3-phenanthrene 
(ng/L) 
hydrocarb
ons 
0.218
357 
0.161
717 
1.350
241 
0.190
667 
-
0.073
72 
0.294
718 
-
0.250
15 
0.804
794 
0.055
244 
0.115
033 
0.480
249 
0.635
791 
4-phenanthrene 
(ng/L) 
hydrocarb
ons 
0.251
556 
0.358
763 
0.701
176 
0.505
827 
0.506
696 
0.343
31 
1.475
914 
0.183
477 
0.418
514 
0.314
289 
1.331
62 
0.224
709 
9-fluorene (ng/L) hydrocarb
ons 
0.142
525 
0.218
231 
0.653
096 
0.534
549 
0.607
338 
0.398
599 
1.523
681 
0.171
41 
0.104
061 
0.273
123 
0.381
004 
0.714
5 
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Table S-4 (Continued) 
Beta-
hexachlorocyclohexan
e (ng/g) 
pesticides 
organochl
orine 
-
0.148
19 
0.378
722 
-
0.391
28 
0.697
959 
2.273
244 
1.165
42 
1.950
579 
0.058
926 
0.285
804 
0.153
933 
1.856
674 
0.071
556 
Dieldrin (ng/g) pesticides 
organochl
orine 
-
0.798
17 
0.360
646 
-
2.213
16 
0.037
565 
0.794
884 
0.268
239 
2.963
337 
0.007
178 
0.368
333 
0.220
887 
1.667
519 
0.109
585 
Heptachlor Epoxide 
(ng/g) 
pesticides 
organochl
orine 
-
0.427
26 
0.263
787 
-
1.619
71 
0.115
108 
1.150
646 
0.550
449 
2.090
376 
0.043
914 
0.148
973 
0.123
834 
1.203
005 
0.237
285 
Hexachlorobenzene 
(ng/g) 
pesticides 
organochl
orine 
0.272
628 
0.229
398 
1.188
45 
0.242
658 
-
0.015
01 
0.815
449 
-
0.018
4 
0.985
417 
1.085
708 
0.437
033 
2.484
27 
0.017
77 
Mirex (ng/g) pesticides 
organochl
orine 
-
0.300
09 
0.253
584 
-
1.183
39 
0.244
629 
-
0.471
44 
0.541
251 
-
0.871
01 
0.389
52 
-
0.004
74 
0.384
876 
-
0.012
31 
0.990
244 
o,p'-DDT (ng/g) pesticides 
organochl
orine 
-
0.149
57 
0.163
553 
-
0.914
53 
0.367
278 
0.170
83 
0.695
568 
0.245
597 
0.807
428 
-
0.099
2 
0.580
47 
-
0.170
89 
0.865
321 
Oxychlordane (ng/g) pesticides 
organochl
orine 
-
0.668
03 
0.312
621 
-
2.136
86 
0.040
353 
2.352
571 
1.608
469 
1.462
615 
0.152
495 
0.328
53 
0.277
036 
1.185
874 
0.243
894 
p,p'-DDE (ng/g) pesticides 
organochl
orine 
-
0.056
93 
0.250
024 
-
0.227
7 
0.821
202 
1.910
57 
1.007
303 
1.896
719 
0.065
911 
-
0.229
39 
0.382
594 
-
0.599
56 
0.552
555 
p,p'-DDT (ng/g) pesticides 
organochl
orine 
-
0.213
7 
0.260
199 
-
0.821
3 
0.417
553 
1.067
588 
0.481
783 
2.215
911 
0.033
295 
-
0.267
59 
0.172
096 
-
1.554
9 
0.129
229 
Trans-nonachlor 
(ng/g) 
pesticides 
organochl
orine 
-
0.482
35 
0.434
618 
-
1.109
83 
0.274
639 
1.180
658 
1.206
773 
0.978
36 
0.334
426 
0.304
251 
0.486
862 
0.624
922 
0.535
963 
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Table S-4 (Continued) 
diethylaminomethylpy
rimidinol/one 
pesticides 
organopho
sphate 
-
0.043
29 
0.208
042 
-
0.208
07 
0.841
102 
-
0.157
23 
0.053
219 
-
2.954
41 
0.021
273 
-
0.407
54 
0.158
286 
-
2.574
7 
0.036
755 
dichlorovnl-dimeth 
prop carboacid 
pesticides 
pyrethyroi
d 
0.104
396 
0.094
995 
1.098
969 
0.284
836 
-
0.122
33 
0.108
625 
-
1.126
19 
0.272
792 
0.011
289 
0.135
935 
0.083
046 
0.934
602 
Mono-(2-ethyl)-hexyl 
phthalate 
phthalates 0.303
944 
0.145
916 
2.082
997 
0.044
415 
0.132
062 
0.196
781 
0.671
112 
0.506
433 
-
0.011
14 
0.138
109 
-
0.080
66 
0.936
158 
Mono-(2-ethyl-5-
hydroxyhexyl) 
phthalate 
phthalates 0.240
962 
0.114
982 
2.095
648 
0.047
839 
0.308
244 
0.224
787 
1.371
275 
0.184
116 
-
0.197
45 
0.133
768 
-
1.476
07 
0.154
095 
Mono-(2-ethyl-5-
oxohexl) phthalate 
phthalates 0.258
362 
0.116
991 
2.208
397 
0.037
939 
0.254
193 
0.220
404 
1.153
309 
0.261
161 
-
0.208
95 
0.138
192 
-
1.512
01 
0.144
765 
Mono-(3-
carboxypropyl) 
phthalate 
phthalates 0.276
345 
0.168
68 
1.638
279 
0.115
588 
-
0.041
09 
0.191
873 
-
0.214
13 
0.832
42 
0.037
639 
0.255
062 
0.147
567 
0.884
028 
Mono-benzyl phthalate phthalates 0.260
244 
0.153
823 
1.691
845 
0.099
316 
0.017
538 
0.161
689 
0.108
469 
0.914
226 
-
0.039
23 
0.090
982 
-
0.431
2 
0.668
896 
Mono-cyclohexyl 
phthalate 
phthalates 0.291
352 
0.163
361 
1.783
483 
0.082
941 
0.375
08 
0.185
099 
2.026
374 
0.050
184 
0.289
21 
0.105
754 
2.734
756 
0.009
625 
Mono-ethyl phthalate phthalates -
0.069
99 
0.099
508 
-
0.703
33 
0.486
372 
-
0.096
15 
0.188
376 
-
0.510
41 
0.612
878 
-
0.166
27 
0.156
108 
-
1.065
09 
0.293
927 
Mono-isobutyl 
phthalate 
phthalates 0.212
335 
0.122
732 
1.730
072 
0.097
624 
0.063
342 
0.274
481 
0.230
769 
0.819
627 
-
0.212
7 
0.136
944 
-
1.553
17 
0.134
651 
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Table S-4 (Continued) 
Mono-isononyl 
phthalate 
phthalates 0.089
359 
0.137
597 
0.649
427 
0.520
185 
0.206
963 
0.156
971 
1.318
475 
0.195
672 
0.107
535 
0.046
729 
2.301
251 
0.027
275 
Mono-n-butyl 
phthalate 
phthalates 0.283
59 
0.127
223 
2.229
081 
0.032
14 
0.209
433 
0.222
389 
0.941
741 
0.352
602 
-
0.001 
0.116
323 
-
0.008
62 
0.993
171 
Mono-n-methyl 
phthalate 
phthalates 0.399
49 
0.131
883 
3.029
116 
0.006
164 
-
0.313
18 
0.241
392 
-
1.297
41 
0.207
931 
-
0.012
39 
0.137
469 
-
0.090
1 
0.929
021 
Mono-n-octyl 
phthalate 
phthalates 0.440
466 
0.154
442 
2.851
988 
0.007
153 
0.443
475 
0.106
523 
4.163
206 
0.000
187 
0.220
377 
0.114
976 
1.916
726 
0.063
237 
Daidzein (ng/mL) phytoestro
gens 
-
0.047
62 
0.153
046 
-
0.311
14 
0.757
487 
0.076
139 
0.176
571 
0.431
207 
0.668
889 
-
0.107
14 
0.117
824 
-
0.909
36 
0.369
208 
Enterodiol (ng/mL) phytoestro
gens 
-
0.062
8 
0.122
037 
-
0.514
58 
0.609
991 
-
0.086
83 
0.140
006 
-
0.620
21 
0.539
024 
0.049
848 
0.147
676 
0.337
548 
0.737
665 
Enterolactone (ng/mL) phytoestro
gens 
0.196
176 
0.132
017 
1.485
996 
0.145
986 
-
0.206
85 
0.233
187 
-
0.887
04 
0.380
947 
0.031
629 
0.127
648 
0.247
785 
0.805
708 
Equol (ng/mL) phytoestro
gens 
0.397
63 
0.144
497 
2.751
816 
0.009
552 
0.090
977 
0.193
989 
0.468
981 
0.641
911 
0.056
926 
0.149
364 
0.381
12 
0.705
354 
Genistein (ng/mL) phytoestro
gens 
0.024
365 
0.176
901 
0.137
733 
0.891
219 
-
0.030
9 
0.181
768 
-
0.170
01 
0.865
951 
-
0.165
05 
0.107
028 
-
1.542
09 
0.131
796 
o-
Desmethylangolensin 
(O-DMA) (ng/mL) 
phytoestro
gens 
-
0.087
84 
0.139
193 
-
0.631
05 
0.531
992 
0.243
712 
0.168
01 
1.450
583 
0.155
554 
0.049
518 
0.141
459 
0.350
048 
0.728
342 
Diethyldithiophosphat
e (ug/L) 
diakyl 0.015
907 
0.229
224 
0.069
396 
0.945
069 
0.125
791 
0.192
309 
0.654
11 
0.517
198 
0.335
963 
0.193
261 
1.738
392 
0.090
689 
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Table S-4 (Continued) 
Diethylphosphate 
(ug/L) 
diakyl -
0.245
29 
0.112
026 
-
2.189
6 
0.035
309 
-
0.285
25 
0.157
243 
-
1.814
06 
0.078
011 
0.403
184 
0.125
592 
3.210
26 
0.002
789 
Diethylthiophosphate 
(ug/L) 
diakyl -
0.039
78 
0.203
009 
-
0.195
95 
0.845
779 
-
0.096
55 
0.155
482 
-
0.620
98 
0.538
524 
0.331
218 
0.159
286 
2.079
396 
0.044
764 
Dimethyldithiophosph
ate (ug/L) 
diakyl 0.147
498 
0.186
456 
0.791
064 
0.434
235 
0.049
954 
0.210
598 
0.237
2 
0.813
847 
0.146
858 
0.153
237 
0.958
369 
0.344
269 
Dimethylphosphate 
(ug/L) 
diakyl -
0.150
99 
0.154
49 
-
0.977
34 
0.335
107 
-
0.080
79 
0.191
097 
-
0.422
79 
0.674
962 
-
0.018
38 
0.129
464 
-
0.141
97 
0.887
895 
Dimethylthiophosphat
e (ug/L) 
diakyl -
0.144
69 
0.220
902 
-
0.655 
0.516
747 
0.088
632 
0.233
1 
0.380
232 
0.706
008 
-
0.103
08 
0.118
769 
-
0.867
87 
0.391
212 
1,2,3,4,6,7,8,9-ocdd 
(fg/g) 
dioxins 0.170
45 
0.154
289 
1.104
745 
0.276
807 
0.090
158 
0.341
88 
0.263
712 
0.793
506 
0.399
927 
0.136
142 
2.937
579 
0.005
738 
1,2,3,4,6,7,8-hpcdd 
(fg/g) 
dioxins 0.009
482 
0.199
868 
0.047
442 
0.962
431 
0.331
62 
0.217
723 
1.523
13 
0.136
463 
0.383
601 
0.205
595 
1.865
812 
0.070
232 
1,2,3,4,7,8-hxcdd 
(fg/g) 
dioxins 0.297
572 
0.266
374 
1.117
118 
0.275
996 
-
0.021
33 
0.322
762 
-
0.066
1 
0.947
896 
-
0.210
49 
0.170
627 
-
1.233
64 
0.230
353 
1,2,3,6,7,8-hxcdd 
(fg/g) 
dioxins 0.254
076 
0.280
417 
0.906
064 
0.371
098 
-
0.023
93 
0.413
586 
-
0.057
87 
0.954
172 
-
0.139
4 
0.192
961 
-
0.722
41 
0.474
712 
1,2,3,7,8,9-hxcdd 
(fg/g) 
dioxins 0.288
626 
0.160
451 
1.798
839 
0.080
672 
0.171
949 
0.191
716 
0.896
895 
0.375
734 
0.015
35 
0.158
264 
0.096
991 
0.923
272 
1,2,3,7,8-pncdd (fg/g) dioxins 0.471
948 
0.171
903 
2.745
432 
0.009
475 
0.021
136 
0.205
721 
0.102
742 
0.918
738 
-
0.005
84 
0.139
344 
-
0.041
89 
0.966
817 
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Table S-4 (Continued) 
2,3,7,8-tcdd (fg/g) dioxins 0.564
735 
0.196
365 
2.875
952 
0.006
814 
0.451
448 
0.191
537 
2.356
98 
0.023
983 
0.176
32 
0.094
173 
1.872
301 
0.069
306 
1,2,3,4,6,7,8-hpcdf 
(fg/g) 
furans 
dibenzofur
an 
-
0.228
14 
0.177
98 
-
1.281
81 
0.208
337 
0.451
787 
0.289
108 
1.562
692 
0.126
874 
0.007
22 
0.174
743 
0.041
32 
0.967
269 
1,2,3,4,7,8-hxcdf (fg/g) furans 
dibenzofur
an 
0.264
757 
0.250
609 
1.056
451 
0.298 0.250
093 
0.206
896 
1.208
786 
0.234
625 
-
0.013
86 
0.162
193 
-
0.085
46 
0.932
369 
1,2,3,6,7,8-hxcdf (fg/g) furans 
dibenzofur
an 
0.219
476 
0.208
454 
1.052
874 
0.299
613 
0.272
615 
0.226
089 
1.205
785 
0.235
766 
0.075
479 
0.207
27 
0.364
159 
0.717
87 
1,2,3,7,8-pncdd (fg/g) furans 
dibenzofur
an 
0.471
948 
0.171
903 
2.745
432 
0.009
475 
0.021
136 
0.205
721 
0.102
742 
0.918
738 
-
0.005
84 
0.139
344 
-
0.041
89 
0.966
817 
2,3,4,6,7,8-hxcdf (fg/g) furans 
dibenzofur
an 
0.157
996 
0.215
413 
0.733
454 
0.468
166 
0.030
284 
0.183
565 
0.164
979 
0.869
883 
0.011
966 
0.121
371 
0.098
589 
0.922
012 
2,3,4,7,8-pncdf (fg/g) furans 
dibenzofur
an 
0.008
424 
0.179
411 
0.046
954 
0.962
817 
0.063
369 
0.232
283 
0.272
81 
0.786
558 
-
0.015
7 
0.170
291 
-
0.092
19 
0.927
061 
Iodine, urine (ng/mL) heavy 
metals 
0.027
368 
0.189
208 
0.144
646 
0.886
307 
-
0.121
02 
0.248
167 
-
0.487
65 
0.630
619 
-
0.045
1 
0.170
159 
-
0.265
02 
0.793
46 
PCB101 (ng/g) pcb 0.024
025 
0.152
891 
0.157
141 
0.876
037 
0.488
146 
0.208
963 
2.336
042 
0.025
175 
0.263
927 
0.113
478 
2.325
797 
0.025
778 
PCB105 (ng/g) pcb 0.440
341 
0.143
739 
3.063
481 
0.004
192 
0.676
743 
0.152
523 
4.437 8.27E
-05 
0.295
4 
0.106
165 
2.782
473 
0.008
536 
PCB118 (ng/g) pcb 0.003
495 
0.211
356 
0.016
537 
0.986
9 
0.114
94 
0.311
899 
0.368
516 
0.714
647 
0.168
41 
0.098
646 
1.707
222 
0.096
393 
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Table S-4 (Continued) 
PCB138 & 158 (ng/g) pcb 0.443
655 
0.196
413 
2.258
784 
0.030
232 
0.269
275 
0.326
343 
0.825
131 
0.414
732 
0.137
956 
0.138
877 
0.993
365 
0.327
162 
PCB146 (ng/g) pcb 0.487
197 
0.171
164 
2.846
373 
0.007
347 
0.704
784 
0.258
603 
2.725
348 
0.009
854 
0.168
259 
0.178
55 
0.942
366 
0.352
286 
PCB153 (ng/g) pcb 0.526
042 
0.207
649 
2.533
322 
0.015
933 
0.425
314 
0.386
817 
1.099
522 
0.278
839 
0.171
176 
0.151
27 
1.131
59 
0.265
289 
PCB156 (ng/g) pcb 0.421
678 
0.234
707 
1.796
617 
0.081
032 
0.409
772 
0.317
214 
1.291
784 
0.204
664 
0.260
489 
0.136
832 
1.903
711 
0.064
966 
PCB157 (ng/g) pcb 0.711
566 
0.276
211 
2.576
166 
0.014
369 
1.708
359 
0.439
527 
3.886
81 
0.000
433 
0.488
723 
0.176
591 
2.767
537 
0.008
864 
PCB167 (ng/g) pcb 0.513
061 
0.192
954 
2.658
976 
0.011
74 
1.219
61 
0.490
6 
2.485
956 
0.017
698 
0.418
861 
0.179
063 
2.339
182 
0.024
993 
PCB170 (ng/g) pcb 0.614
861 
0.201
781 
3.047
165 
0.004
375 
0.352
742 
0.374
942 
0.940
791 
0.353
083 
0.141
185 
0.168
6 
0.837
395 
0.407
896 
PCB172 (ng/g) pcb 0.826
607 
0.242
681 
3.406
153 
0.001
669 
1.615
604 
0.392
052 
4.120
896 
0.000
212 
0.448
731 
0.181
21 
2.476
303 
0.018
111 
PCB177 (ng/g) pcb 0.697
588 
0.214
455 
3.252
832 
0.002
533 
1.193
737 
0.301
021 
3.965
624 
0.000
333 
0.492
907 
0.166
808 
2.954
936 
0.005
486 
PCB178 (ng/g) pcb 0.882
685 
0.261
445 
3.376
182 
0.001
812 
1.142
084 
0.289
373 
3.946
751 
0.000
352 
0.402
48 
0.160
51 
2.507
511 
0.016
808 
PCB180 (ng/g) pcb 0.572
456 
0.233
494 
2.451
695 
0.019
352 
0.183
569 
0.490
601 
0.374
172 
0.710
472 
0.016
883 
0.165
369 
0.102
093 
0.919
249 
PCB183 (ng/g) pcb 0.758
059 
0.189
333 
4.003
834 
0.000
309 
0.776
924 
0.253
475 
3.065
085 
0.004
11 
0.369
704 
0.148
621 
2.487
557 
0.017
631 
PCB187 (ng/g) pcb 0.547
362 
0.202
73 
2.699
958 
0.010
61 
0.432
98 
0.339
483 
1.275
409 
0.210
334 
0.122
354 
0.106
493 
1.148
934 
0.258
16 
PCB194 (ng/g) pcb 0.479
839 
0.346
957 
1.382
993 
0.180
544 
0.662
725 
0.406
614 
1.629
863 
0.117
366 
0.241
79 
0.149
791 
1.614
177 
0.120
742 
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Table S-4 (Continued) 
PCB196 & 203 (ng/g) pcb 0.644
542 
0.298
089 
2.162
246 
0.041
742 
0.650
676 
0.507
848 
1.281
24 
0.213
45 
0.180
816 
0.162
316 
1.113
975 
0.277
313 
PCB199 (ng/g) pcb 0.812
626 
0.372
457 
2.181
797 
0.040
091 
0.695
078 
0.473
346 
1.468
435 
0.156
14 
0.244
743 
0.133
58 
1.832
189 
0.080
496 
PCB206 (ng/g) pcb 1.227
179 
0.308
254 
3.981
063 
0.000
632 
1.745
862 
0.593
612 
2.941
084 
0.007
557 
0.616
422 
0.216
337 
2.849
354 
0.009
326 
PCB28 (ng/g) pcb -
0.012
8 
0.284
64 
-
0.044
98 
0.964
571 
0.691
701 
0.232
285 
2.977
808 
0.007
176 
0.500
249 
0.186
23 
2.686
183 
0.013
827 
PCB52 (ng/g) pcb 0.362
356 
0.211
564 
1.712
749 
0.095
606 
0.255
947 
0.128
562 
1.990
846 
0.054
13 
0.155
426 
0.118
936 
1.306
809 
0.199
564 
PCB66 (ng/g) pcb 0.434
718 
0.165
685 
2.623
757 
0.012
799 
0.637
3 
0.139
214 
4.577
837 
5.42E
-05 
0.195
128 
0.129
303 
1.509
075 
0.140
007 
PCB74 (ng/g) pcb 0.118
582 
0.225
883 
0.524
974 
0.602
911 
-
0.017
43 
0.320
4 
-
0.054
4 
0.956
914 
0.180
432 
0.110
374 
1.634
732 
0.110
821 
PCB99 (ng/g) pcb 0.275
84 
0.127
813 
2.158
153 
0.037
859 
0.268
164 
0.242
109 
1.107
616 
0.275
374 
0.177
976 
0.107
563 
1.654
624 
0.106
695 
3,3',4,4',5,5'-hxcb 
(fg/g) 
pcbs 0.491
683 
0.236
414 
2.079
754 
0.044
937 
0.060
688 
0.406
45 
0.149
312 
0.882
141 
-
0.070
21 
0.178
408 
-
0.393
53 
0.696
249 
3,3',4,4',5-pncb (fg/g) pcbs 0.031
127 
0.258
638 
0.120
349 
0.904
895 
-
0.072
61 
0.314
864 
-
0.230
61 
0.818
921 
-
0.073
13 
0.170
983 
-
0.427
71 
0.671
411 
Metolachlor 
mercapturate result 
pesticides 
chloroacet
anilide 
-
3.542
04 
0.152
971 
-
23.15
51 
7.11E
-08 
-
4.183
9 
0.292
519 
-
14.30
3 
1.94E
-06 
0.086
772 
0.154
259 
0.562
507 
0.591
321 
2,4,5-trichlorophenol 
(ug/L) result 
pesticides 
phenols 
0.037
083 
0.397
87 
0.093
204 
0.928
353 
-
0.055
94 
0.671
641 
-
0.083
29 
0.935
951 
0.027
296 
0.357
879 
0.076
273 
0.941
336 
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Table S-4 (Continued) 
2,4,6-trichlorophenol 
(ug/L) result 
pesticides 
phenols 
-
0.456
35 
0.374
892 
-
1.217
27 
0.262
94 
-
0.049
83 
0.574
378 
-
0.086
76 
0.933
294 
0.256
334 
0.147
618 
1.736
463 
0.126
057 
2,4-dichlorophenol 
(ug/L) result 
pesticides 
phenols 
-
0.184
34 
0.219
938 
-
0.838
14 
0.407
641 
-
0.087
21 
0.145
86 
-
0.597
9 
0.553
649 
-
0.248
82 
0.144
426 
-
1.722
84 
0.093
498 
2,5-dichlorophenol 
(ug/L) result 
pesticides 
phenols 
0.039
555 
0.310
881 
0.127
237 
0.902
331 
0.889
206 
0.730
132 
1.217
87 
0.262
727 
0.406
178 
0.294
178 
1.380
72 
0.209
838 
O-Phenyl phenol 
(ug/L) result 
pesticides 
phenols 
0.012
541 
0.251
15 
0.049
936 
0.961
569 
0.442
439 
0.490
258 
0.902
461 
0.396
802 
-
0.319
72 
0.343
386 
-
0.931
09 
0.382
798 
Pentachlorophenol 
(ug/L) 
pesticides 
phenols 
-
1.166
51 
0.732
035 
-
1.593
51 
0.155
074 
0.258
379 
0.687
339 
0.375
912 
0.718
116 
0.072
865 
0.292
926 
0.248
75 
0.810
695 
Urinary 4-tert-octyl 
phenol (ng/mL) 
phenols -
0.576
79 
0.327
926 
-
1.758
91 
0.121
997 
0.662
601 
0.540
105 
1.226
8 
0.259
556 
-
0.401
48 
0.357
221 
-
1.123
91 
0.298
112 
Urinary 
Benzophenone-3 
(ng/mL) 
phenols 0.059
192 
0.248
925 
0.237
791 
0.818
853 
0.834
738 
0.654
808 
1.274
783 
0.243
067 
-
0.584
96 
0.289
912 
-
2.017
71 
0.083
412 
Urinary Bisphenol A 
(ng/mL) 
phenols 0.152
376 
0.361
635 
0.421
354 
0.686
133 
0.567
709 
0.711
272 
0.798
159 
0.451
002 
0.088
095 
0.281
042 
0.313
458 
0.763
067 
Blood 1,1,1-
Trichloroethane 
(ng/mL) 
volatile 
compound
s 
-
0.400
89 
0.374
024 
-
1.071
84 
0.301
922 
-
0.493
29 
0.363
563 
-
1.356
83 
0.189
953 
0.149
261 
0.159
753 
0.934
322 
0.361
861 
Blood 1,4-
Dichlorobenzene 
(ng/mL) 
volatile 
compound
s 
-
0.050
74 
0.171
432 
-
0.295
95 
0.769
81 
-
0.061
6 
0.266
996 
-
0.230
7 
0.819
222 
0.154
631 
0.111
548 
1.386
228 
0.175
568 
Blood Benzene 
(ng/mL) 
volatile 
compound 
0.287
982 
0.211
651 
1.360
648 
0.186
267 
0.231
449 
0.283
127 
0.817
474 
0.420
103 
0.074
543 
0.189
276 
0.393
829 
0.696
319 
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Table S-4 (Continued) 
Blood 
Bromodichloromethan
e (pg/mL) 
volatile 
compound
s 
0.303
218 
0.171
205 
1.771
076 
0.090
403 
0.149
054 
0.358
412 
0.415
873 
0.681
051 
-
0.082
28 
0.173
699 
-
0.473
72 
0.639
248 
Blood Bromoform 
(pg/mL) 
volatile 
compound
s 
0.010
775 
0.328
84 
0.032
767 
0.974
17 
-
0.265
52 
0.370
639 
-
0.716
39 
0.480
664 
-
0.077
26 
0.220
593 
-
0.350
26 
0.728
767 
Blood Carbon 
Tetrachloride (ng/mL) 
volatile 
compound
s 
0.187
361 
0.163
881 
1.143
273 
0.265
792 
0.177
644 
0.203
352 
0.873
579 
0.390
345 
0.185
653 
0.139
106 
1.334
616 
0.192
387 
Blood Chloroform 
(pg/mL) 
volatile 
compound
s 
-
0.151
8 
0.205
177 
-
0.739
87 
0.467
572 
0.074
222 
0.408
178 
0.181
836 
0.857
238 
0.018
792 
0.171
661 
0.109
473 
0.913
668 
Blood 
Dibromochloromethan
e (pg/mL) 
volatile 
compound
s 
0.154
216 
0.172
89 
0.891
99 
0.382
051 
-
0.078
59 
0.330
748 
-
0.237
62 
0.814
11 
-
0.226
88 
0.139
239 
-
1.629
44 
0.114
037 
Blood Ethylbenzene 
(ng/mL) 
volatile 
compound
s 
0.073
71 
0.187
934 
0.392
214 
0.697
979 
-
0.427
64 
0.391
612 
-
1.092 
0.282
986 
-
0.065
75 
0.306
132 
-
0.214
79 
0.831
147 
Blood m-/p-Xylene 
(ng/mL) 
volatile 
compound
s 
0.240
959 
0.229
089 
1.051
813 
0.301
879 
-
0.165
63 
0.285
647 
-
0.579
84 
0.566
084 
-
0.220
72 
0.194
45 
-
1.135
1 
0.263
835 
Blood MTBE (pg/mL) volatile 
compound
s 
0.053
51 
0.241
662 
0.221
424 
0.827
124 
0.326
375 
0.199
515 
1.635
844 
0.117
513 
-
0.041
72 
0.340
737 
-
0.122
44 
0.903
613 
Blood o-Xylene 
(ng/mL) 
volatile 
compound
s 
0.189
804 
0.180
689 
1.050
449 
0.302
494 
-
0.071
61 
0.204
897 
-
0.349
51 
0.728
93 
0.075
456 
0.164
846 
0.457
74 
0.649
89 
Blood Styrene (ng/mL) volatile 
compound
s 
0.170
102 
0.211
335 
0.804
893 
0.427
664 
0.082
323 
0.116
722 
0.705
293 
0.486
068 
-
0.217
53 
0.319
535 
-
0.680
78 
0.500
492 
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Table S-4 (Continued) 
Blood 
Tetrachloroethene 
(ng/mL) 
volatile 
compound
s 
0.133
679 
0.144
304 
0.926
367 
0.362
172 
-
0.221
68 
0.402
371 
-
0.550
93 
0.585
392 
-
0.094
84 
0.176
462 
-
0.537
45 
0.594
263 
Blood Toluene 
(ng/mL) 
volatile 
compound
s 
0.394
79 
0.260
401 
1.516
081 
0.140
708 
-
0.044
03 
0.323
274 
-
0.136
19 
0.892
523 
0.024
013 
0.164
448 
0.146
021 
0.884
72 
Blood Trichloroethene 
(ng/mL) 
volatile 
compound
s 
0.426
415 
0.202
828 
2.102
345 
0.044
641 
0.211
529 
0.276
157 
0.765
973 
0.449
486 
0.050
715 
0.105
437 
0.480
997 
0.633
429 
Water 
Bromodichloromethan
e (ng/mL) 
volatile 
compound
s 
0.355
678 
0.185
785 
1.914
459 
0.064
265 
-
0.057
05 
0.249
216 
-
0.228
93 
0.820
296 
-
0.187
77 
0.154
585 
-
1.214
65 
0.232
408 
Water Bromoform 
(ng/mL) 
volatile 
compound
s 
0.042
214 
0.160
309 
0.263
329 
0.793
934 
-
0.040
53 
0.206
902 
-
0.195
89 
0.845
864 
-
0.051
97 
0.145
194 
-
0.357
92 
0.722
497 
Water Chloroform 
(ng/mL) 
volatile 
compound 
0.342
489 
0.182
222 
1.879
518 
0.069
028 
-
0.056 
0.243
68 
-
0.231 
0.818
393 
-
0.162 
0.138
606 
-
1.175 
0.247
514 
Water 
Dibromochloromethan
e (ng/mL) 
volatile 
compound 
0.278
804 
0.157
521 
1.769
947 
0.085
976 
0.023
486 
0.227
225 
0.103
361 
0.918
284 
-
0.159 
0.179
29 
-
0.889 
0.379
697 
Water MTBE (ng/mL) volatile 
compound 
0.049
793 
0.193
632 
0.257
153 
0.798
657 
-
0.138 
0.232
977 
-
0.594 
0.556
033 
0.038
747 
0.128
854 
0.300
708 
0.765
367 
Note:  
(1) The p-values are calculated based on the survey weighted logistic regression with dichotomous periodontitis status as the 
outcome adjusting for age, gender, ethnicity, socioeconomic status and number of teeth.  
(2) The p-value of 0.01 is determined based on the overall FDR of 5%. A significance of 0.01 corresponds to a FDR of 8%, 10%, and 
13% for the current, former, and non-smokers cohort, respectively. 
(3) The highlighted cells are p-values that are smaller than 0.01. 
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Chapter Five 
Conclusions and Future Work 
 
This chapter provides an overview summary of each paper and discusses the oral 
health implication and future work of the research presented in this dissertation.  The 
chapter also discusses the strengths and limitations of this research.  There are three papers 
presented in this dissertation: (1) “A Simple Tool for Identifying Children with Untreated 
Dental Caries: A Cross-Sectional Study of Low-Income Children”; (2) “Visualizing the Co-
Morbidity Burden in Children with Pediatric Autism and Impact on Access to 
Comprehensive Oral Health Care”; and (3) “Environmental-Wide Association Study for 
Periodontitis using NHANES.”  The oral health outcomes studied in the three papers cover 
the most prevalent and concerning public health issues. 
The first paper (Chapter Two) is a secondary data analysis that seeks to identify 
factors associated with untreated decay in a low socio-economic population.  The goal is to 
identify key factors that could be used outside of a dental exam, providing a potential 
assessment tool for pediatricians for referring children for dental care.  Classification 
regression tree (CART) analysis is employed to explore the multidimensional factors and 
potential interactive effects among factors reported by parents.  The study shows that 34% 
of the children aged 0-5 have at least one untreated dental caries.  The study suggests that 
for children older than 2, parents’ assessment of their own and their children’s teeth 
condition could be used as standard screening questions for untreated dental caries during 
a regular health care visit.  Specifically, the tool can correctly identify 78% of the children as 
caries-free and 43% as having untreated dental decay given the response of their parents.  
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The strength of the study is the ability to identify risk factors associated with 
untreated dental caries beyond the socio-economical determinant for children requiring 
dental referrals.  While social attributes may predispose children to elevated risks of dental 
caries, the well-rounded knowledge associated with behavioral risk factors and parental 
assessment is crucial for public health professionals to manage unmet oral care needs. 
Additionally, the use of CART provides a graphical picture and a convenient means 
for physicians to discern potential risks.  In epidemiological research, it is critically 
important for health professionals to be able to easily define and identify subpopulations 
with similar characteristics but different health risk profiles to target for intervention and 
prevention (Lemon et al., 2003).  In the presence of numerous potential risk factors of 
interest, the process of segmenting subgroups using traditional approaches such as 
bivariate and multi-variable regression analysis becomes cumbersome and unrealistic.  On 
contrary, CART is not only designed to handle analysis involving a large number of 
correlated variables without causing a statistical concern, but also has the analytical 
capability to create meaningful subsets by going beyond the estimation of the “average” 
effect.  Thus, the tool provides a great potential for policy making by appropriately identify 
target groups and maximize the public health resources.  
While the study achieves a specificity of 78%, the study is limited to include 
important predictor variables such as parents/child risk behaviors and oral hygiene 
practices (Petersen 2003).  Longitudinal assessment of this referral recommendation 
should also be considered in future studies; identifying factors that could be used to 
ascertain caries risk would help with referrals and the prevention of dental caries. 
The second paper (Chapter 3) examines the co-morbidity burden and its implication 
on oral health care for children with autism.  The prevalence of autism in children has been 
increasing, and unmet oral health care needs are commonly reported for these children 
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(Jaber 2011; Chiri 2012; Kogan 2008).  The study utilizes hospital chart data for children 
receiving dental treatment under general anesthesia in a hospital setting, which provides a 
unique opportunity to evaluate co-morbid conditions and the oral health status of children 
with autism.  Among all pediatric patients in this study, 19% are diagnosed with childhood 
autism.  While children with autism do not exhibit a particularly high rate of dental caries 
compared to other pediatric patients treated in the hospital, the use of network plots help to 
visualize the additional concurrent psychological and developmental disorders (greater 
disease burden) that children diagnosed with autism face.  Moreover, the network plot is 
used to visualize and compare the “connectedness” of concurrent health conditions.  By 
comparing the network plots of children treated in the hospital without an autism 
diagnosis, children with autism appear to have more connections to other conditions.  By 
understanding the disease burden associated with autism, future planning on policies and 
financial relocation are possible.  The use of network plots in this analysis allows the 
presentation of the complex disease burden as well as the comparison between target 
groups, which would have been difficult using conventional listing and prevalence reporting 
methods. 
The results of the study suggest that due to the heavy disease burden for children 
with autism, it is necessary to avoid fragmenting the health care access by treating these 
children in a hospital.  To ease the long wait lists and high costs for dental general 
anesthesia, strategies need to be determined to support hospitals and implementation for 
projecting future demand. 
The third paper (chapter 4) examines analytical methods to search for variables 
associated with periodontal diseases among a wide spectrum of environmental factors.  
Periodontitis is known for its multifactorial nature, implying that the development and the 
progression of the disease can be caused by various factors, including environmental toxins 
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and the interactions between the risk factors.  To systematically evaluate the relationships 
between the disease and potential environmental determinants measured in the National 
Health and Nutritional Survey (NHANES), random forests are used to select variables 
deemed as “important” in classifying individuals with the disease.  Classification regression 
tree is also carried out as a second step to investigate associations and visualize potential 
interactions between environmental factors.  The results of the study show that in addition 
to the well-known risk factors (such as Lead, cotinine, age, gender, ses, and race), additional 
environmental variables are identified for future research.  For example, several nutrients 
(i.e. carotenoids, and serum folate) are shown to have beneficial effect on periodontal 
health.  Other environmental toxins such as dioxins and phthalates are shown to be 
adversely related to periodontitis.  Compared to adjusted main effects analyses, random 
forests provide a smaller set of “informative” variables, which allow linearity and 
interactions to be examined further without having assumptions about the functional form 
of the data.   
To the best of our knowledge, it is the first time that random forests have been 
utilized to investigate highly correlated environmental variables.  This methodology adds a 
great value in this association study to accommodate nonlinearities and interactions 
without explicitly specifying them. 
While data exploratory techniques and visualization tools provide an easy-to-use 
and powerful means to explore data and uncover information, they are required to be 
evaluated with skepticism (Marshall 2000).  For example in CART, it is possible that a set of 
potential symptoms and signs might show an effect on the disease outcome when evaluated 
independently but do not make logical sense when they are combined in a decision making 
tree.  The greatest advantage of tree-based methods, however, is its wide capability to 
different types of data and easy implementation.  
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With advanced computing power and storage, data containing hundreds of fields 
and millions of records are becoming increasingly common (Fayyad et al. 1996).  In a large-
scale data, the traditional approach becomes inefficient and biased due to the subjectivity of 
the prior assumptions on the algorithmic procedures (Wong et al. 2003).  Large public 
health databases (e.g. NHANES, electronic medical charts, WHO oral health databases, and 
surveys of oral health assessment) that utilize information on individuals’ demographics, 
comorbidities, and medical claims to examine patterns of medication use and outcome is 
typically a multi-dimensional problem.  However, describing relationships in high 
dimensional spaces is generally difficult.  Thus, with the advanced capability to collect and 
store massive volumes of data, there is a need to automate the analysis work and uncover 
meaningful patterns and structures from them (Wong et al. 2003).  It is through data mining 
that we could provide the best available evidence to make clinical decisions.  This 
dissertation provides applications of a range of different methodology and visualization and 
tools to explore oral health related data.  By using them, the ideas get transformed and 
delivered more efficiently.  Additionally, these methods can be easily extended to a variety 
of health outcome research where the inherent nature of the data is multidimensional. 
The results of this research echo the need for a better tool to understand the 
multidimensional factors associated with oral health presented in Fisher-Owen’s multilevel 
conceptual model (2007).  It is through the systematic uses of data and appropriate 
analytical techniques that facilitate researchers in public health to translate basic science 
knowledge into new approaches for prevention, diagnosis, and treatments (Woolf 2008). 
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Appendix A – False Discovery Rate (FDR) 
 
False discovery rate (FDR) procedure is an approach that is proposed to control for 
multiple hypothesis testing.  Instead of controlling conservatively on the family wise error 
rate (FWER) (such as Bonferroni’s and Tukey’s adjustment), FDR procedure focuses on 
retaining the number of false discoveries.  The greatest difference between FDR (i.e. 
expected proportion of falsely rejected hypotheses) and false positive rate (i.e. α) can be 
illustrated in the following example.  In testing a list of hypotheses, a false positive rate of 
5% implies that among all hypotheses that are truly null (i.e. do not have an association), 
5% of them are falsely claimed as “significant”; a false discovery rate of 5% implies that 
among those claimed “significant”, 5% of them are truly null.  Multiple hypothesis testing 
correction such as Bonferroni, Tukey, and Holm’s method all exert strong control over 
FWER, which provides measures on the null features instead of features that are called 
significant.  In contrast, the false discovery rate approach which describes the tested 
features’ significance offers a more liberal criterion and avoids producing many false 
positive results. 
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Appendix B – Random Forests (RF) 
 
In the presence of large number of predicators that classical statistical methods 
cannot handle simultaneously, random forest, a high-dimensional non-parametric method 
is considered.  It is also particularly chosen in some circumstances for its ability to allow 
nonlinearities and interactions without modeling them explicitly.  
Background and relation with CART 
Random forests were first introduced as an extension of a single decision tree (i.e. 
classification regression tree proposed by Breiman (2001).  They are built on the basis of a 
collection of individual trees to improve prediction errors.  The simple tree-based method, 
known as the classification regression tree (CART), tries to identify high-risk groups by 
selecting a set of predictors that classify observations into partitions with and without the 
target outcome.  Despite of the fact that tree-based methods are non-parametric, the most 
noticeable difference between the tree-based methods and the regular regression models is 
the modeling structure.  Regression models are known as the main-effect model where all 
variables are fitted in a single model, and their relationships with the response are 
evaluated simultaneously.  In order to justify the use of regression models, several principal 
assumptions such as linearity between the outcome and the predictors, constant variance of 
the errors and normality of the error distribution must hold.  In contrast, tree-based 
methods are assumption-free and examine the influence of predictor variables sequentially.  
That is, the relationship between the predictor variables and the outcome in a specific 
group is only assessed given that the observations met certain criteria.  As this process 
continues, the combinations of factors can be easily visualized by a tree-like plot. 
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Consequently, the hierarchical nature of the tree model enables the identification of 
interactions. 
Nonetheless, given the simplicity and ease of implementation of CART, the major 
disadvantage is the instability to small data changes.  The problem occurs when small 
changes in the dataset from the preceding partition affect the subsequent partitioning 
extensively.  Thus, the predictors elected from a single tree may not be deemed reliable.  
The alternative is to consider a collection of trees (a.k.a. random forests) each formed by a 
random sample of observations and a random sample of predictors.  The goal is to reduce 
the classification prediction error by taking the majority of the votes for classification and 
average for regression.  Random forest is a machine learning technique (meaning to 
discover data through an automated process without explicitly specifying the model) that is 
particularly suitable for data with large interactive effects (Strobl et al., 2009).  The 
contribution of a variable, that may be due to its interactions with other variables, is 
measured by the variable importance value that is computed on the basis of a collection 
trees rather than a single tree.  
Source of Randomness in Random Forests 
As noted previously, there are two sources of randomness in the random forests: 
random selection of variables and random selection of predictors.  In a forest, each tree is 
“grown” using a random sample of the original dataset without replacement.  The procedure 
is known as bagging, where the observations drawn randomly from the original data set 
(i.e. in-bag samples) are used to predict the outcome of the “out-of-bag” observations (i.e. 
observations that are not drawn) (Breiman, 1996).  The rationale behind bagging is that the 
results obtained from the aggregation process are no longer affected by a specific choice of 
the data.  Additionally, within each tree, each node is split based on a subset of a random 
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selection of predictors.  This is critically important and different from the standard trees; in 
standard trees, each node is split using the best splitting variable considering all variables.  
In contrast, the random selection of predictor variables addresses the issues of multi-
collinearity and overshadowing found in simpler models.  Overshadowing takes place when 
the effect of a weaker predictor is overlooked by more significant competitors.  Multi-
collinearity is a phenomenon when two or more highly correlated variables are present in a 
model which affects the estimation and the validity of the fitted model substantially.  The 
benefit of randomly selecting predictors at each split is to reduce the competition between 
similarly important and correlated factors.  As a result, this step adds an extra layer of 
randomness in addition to bagging to produce even more diverse trees and improve the 
predictive performance further (Breiman, 2001).  
There are two parameters in random forests: number of trees grown (ntree) and 
number of predictor variables considered in the splitting process (mtry).  The default 
number of tree is 500 and the suggested number of mtry has a default of p/3 for regression 
forests (Liaw and Wiener, 2002) and sqrt(p) for classification forests (Breiman, 2001). 
Variable Importance Index 
The variable importance (VI) value is a measure of how important a given predictor 
variable is by measuring how much the prediction error increases when “breaking” the 
variable bond to the response (Strobl et al., 2009).  The relationship between the predictor 
and the response can be broken, for example, by randomly permuting the values of variable 
Xj.  Given that the predictor variable contributes significantly to the model, the breakage is 
expected to destroy the bond between them and increase the prediction error.   
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Mathematically, the estimate of VI is sum of the difference of the model accuracy 
before and after the breakage in each tree, averaged over all trees in the forest.  The VI of 
variable Xj in tree t (Strobl et al., 2008) is: 
 
 
For classification forests, 
                                                                              and 
 
For regression forests, 
                                                                              and 
 
where nOOB is the number of observations in the out-of-bag sample, 
)(ˆ t
iy and 
)*(ˆ t
iy  is the 
predicted class/response for observation i before and after breakage for variable Xj, 
respectively.  
The most commonly used and advanced variable importance measure – the 
permutation importance – has been updated recently with the “new importance measure” 
to incorporate missing data (Hapfelmeier et al., 2012).  The major difference between the 
two is that the former randomly shuffles the values of a given independent variable and the 
later randomly assigns each observation with  to the left (or right) of the child node [see 
Hapfelmeier et al. (2012) for step-by-step algorithm and detail computation].  Both methods 
intend to break the variable’s association with the response such that the misclassification 
error rate computed (for each predictor) with and without the random assignment over all 
trees produce an average difference in prediction.  The difference in prediction is deemed 
the VI value because the higher the prediction difference, the greater the contribution of the 
variable, and therefore the more “important” the variable is.  Typically, the VI values of all 
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predictors are sorted from the largest to the smallest.  The importance index not only 
provides the importance measure but also the rank of importance for a given predictor.  
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Appendix C – Periodontitis Literature Review 
Biological mechanism and etiology of periodontal diseases 
 Periodontitis is inflammation of the gums caused by the accumulation of bacterial 
plaque (Michaud et al., 2007; Pihlstrom et al., 2005).  The disease is a threat to oral health 
since disease progression results in destruction of the teeth-supporting bones and soft 
tissues, and eventually leads to tooth loss without proper treatment (Bartold et al., 2010).  
While the disease ranges from mild (known as gingivitis) to chronic and aggressive 
periodontal diseases, the biological mediators and mechanisms are very similar (Bartold et 
al., 2010).  It is evident that the disease is associated with a large accumulation of microbial 
species in the mouth and on the teeth adjacent to the gums (gingival) (Pihlstrom et al., 
2005).  Among a wide variety of bacterial species found in the mouth, Porphyromonas 
gingivalis, Tannerella forsythia and Treponema denticola, known as the “red-complex” 
bacteria, are often found together in the most severe form of periodontal diseases 
(Socransky et al., 1998).  However, these microbial residents are not sufficient to affect the 
supporting structure of the teeth without an inflammation response around the teeth to 
take place first (Bartold et al., 2010).  As the number of bacteria increases to a state that 
triggers inflammation, the inflammatory cytokines are released.  The inflammatory 
cytokines are stimuli that enhance the osteoclast activity and initiate the bone resorption 
process (Bartold et al., 2010).  Osteoclasts are multinucleated cells that can actively dissolve 
alveolar bone (tooth-supporting bone) by releasing de-mineralizing agents and degrading 
enzymes (Schwartz et al., 1997; Teitelbaum, 2000).  As a result of the continuous 
destruction of the teeth-supporting bone and soft tissues, teeth may become loose and 
finally lost.  Periodontal diseases have been the major source of tooth loss in adults 
(Darveau, 2010; Horton et al., 1972). 
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Definition of Periodontitis 
 The extent of periodontal disease is determined by various clinical measurements.   
Typically, the presence of gingival inflammation is measured by clinical attachment loss 
(CAL), and pocket probing depth (PPD) (Savage et al., 2009) (Figure C-1a).  Nonetheless, 
plaque, bleeding on probing (BOP), and visual gingival inflammation can also play a role in 
evaluating the presence of inflammation around the teeth (Eke et al., 2010).  Due to a 
variety of clinical measures, there has been a wide range of different definitions and 
measurements used to describe and diagnose periodontitis. 
 According to the Center for Disease Control (CDC) and Prevention report developed 
in partnership with the American Academy of Periodontology (AAP), the case definitions for 
moderate and severe periodontisis are presented in Table C-1.  Eke et al. (2012) added a 
new definition of mild periodontitis to make the description of the overall prevalence of 
periodontitis more complete.  Nonetheless, other case definitions of periodontitis have also 
been applied in various studies.  Arbes et al. (2001) and the European Federation of 
Periodontology (EFP) (Tonetti and Claffey, 2005) defined periodontitis as having 1 or more 
sites with ≥ 3 mm CAL and ≥ 4 mm PPD.  Tomar and Asma (2000) defined periodontitis as 
the presence of at least one site with CAL of ≥4 mm apical to the cement-enamel junction 
and PPD of ≥4mm.  These threshold values were also shared by Borrell and Talih (2012) 
with a relaxation that these conditions did not need to be present on the same tooth.  
 In some cases, higher threshold for CAL needs to be achieved.  For example, Borrel 
et al. (2005) defined a periodontitis case as having at least 3 sites with CAL > 4 mm and at 
least 2 sites with PPD > 3 mm.  Moderate periodontitis was defined by Kim et al. (2012) 
using a CAL threshold value of ≥4 mm at ≥2 interproximal sites or PPD threshold of ≥5 mm 
at ≥2 interproximal sites (Figure C-1b).  In the same study, severe periodontitis was defined 
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as having ≥2 interproximal sites with CAL ≥ 6 mm and ≥ 1mm interproximal sites with PPD 
≥5 mm.  
 It is also not uncommon to incorporate other determinants such as BOP and/or 
plaque accumulation to diagnose periodontitis (Gomes‐Filho et al., 2007; Oteo et al., 2010; 
Saddki et al., 2007; Tonetti et al., 1994).  However, since a number of studies has 
demonstrated that smoking can effectively inhibit gingival bleeding (Bergström and 
Boström, 2001; Müller et al., 2001), the use of bleeding on probing as an indication of 
gingival inflammation and periodontal diagnosis is less popular. 
 
Table C-1. Case Definition of Periodontitis by CDC-AAP 
Severity of 
Periodontitis 
Definition 
Mild periodontitis†  ≥ 2 interproximal sites with CAL ≥ 3 mm, and ≥ 2 
interproximal sites with PPD ≥ 4 mm (not on same tooth), or 
 one site with PPD ≥ 5 mm 
Moderate 
periodontitis* 
 ≥ 2 interproximal sites with CAL ≥ 4 mm (not on same tooth), 
or 
 ≥ 2 interproximal sites with PPD ≥ 5 mm (not on same tooth) 
Severe periodontitis*  ≥ 2 interproximal sites with CAL ≥ 6 mm (not on same tooth) 
and ≥ 1 interproximal site with PPD ≥ 5 mm 
†Eke et al. (2012) case definitions for mild periodontitis 
*CDC-AAP case definitions for surveillance of periodontitis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 111 
 
Figure C-1a. Normal vs. periodontitis tooth 
      
Figures adapted from Arora et al (2009)   
  
Figure C-1b. Interproximal site of teeth 
 
Figure modified from © American Academy of Periodontology 
[http://www.perio.org/consumer/types-gum-disease.html#OverlayWrapper[flash]/0/] 
 
Prevalence of Periodontitis 
 In clinical practice, periodontal disease is measured by clinical attachment loss 
(CAL) and probing depth (PD), and the prevalence of periodontitis is complicated by various 
case definitions in published studies.  Based on the suggested CDC-AAP case definition of 
periodontitis (Eke et al., 2012; Page and Eke, 2007) (Table C-1), the recent population-
based surveillance data released from the 2009 and 2010 NHANES cycle revealed that the 
prevalence of mild, moderate and severe periodontitis was 8.7%, 30.0%, and 8.5%, 
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respectively (Eke et al., 2012).  The overall prevalence of periodontitis for the adult 
population (aged ≥ 30 years old) calculated by taking the sum of mild, moderate and severe 
periodontitis is 47%.  
 While it has been shown that the prevalence estimates of periodontitis has 
decreased from 1988 to 2004 (Cobb et al., 2009), higher prevalence is observed in older 
adults, male population, Black and Hispanic adults, current smokers, and those with lower 
incomes and education (Borrell and Crawford, 2007; Eke et al., 2012).  
 The incidence rate of periodontitis is often referred to as the annual diagnose rate.  
However, unlike many chronic diseases that are under surveillance, limited incidence 
statistics of periodontitis are reported.  
Risk factors for Periodontitis 
 It has been well documented that periodontal diseases are resulted from the 
interplay of both environmental factors and socio-behavioral factors (Albandar and Rams, 
2002; Van Dyke and Dave, 2005).  For example, smoking, low social economic status, poor 
oral hygiene, psychological stress, depression, increased age, environmental toxins and 
systemic health outcomes are well known risk factors that may aggravate the progression of 
periodontal diseases (Albandar, 2005; Pihlstrom et al., 2005; Stabholz et al., 2010).  Among 
them, smoking is the most significant modifiable risk factor in the pathogenesis of 
periodontitis (Bergström and Preber, 1994).  Not only does the tobacco use have a 
detrimental effect on periodontal health, the number of cigarettes smoked per day is also 
directly related to the prevalence and the severity of the disease (Martinez‐Canut et al., 
2005; Tomar and Asma, 2000).  Studies have also demonstrated that individuals under 
psychological stress may have lower immune system functions to respond to inflammation 
and infections, thereby more likely to experience attachment loss and loss of the alveolar 
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bone (Hugoson et al., 2002; Wimmer et al., 2002).  Other modifiable factors such as oral 
hygiene practices, environmental exposures, and diet are also considered as important risk 
factors that can be treated and controlled (Van Dyke and Dave, 2005).  Despite 
environmental factors, healthy individuals may be more susceptible to develop periodontal 
diseases due to genetic predisposition (Dumitrescu and Kobayashi, 2010).  Other non-
modifiable factors include aging and systemic diseases (Van Dyke and Dave, 2005).  
Periodontal health disparities 
 Despite of the increasing awareness and improvement in oral health, periodontitis, 
together with dental caries, remains as the greatest oral health concerns in the United 
States (Benjamin, 2010).  The socio-demographic disparities in the burden of periodontitis 
reported in the NHANES data (2009-2010) are consistent with previous versions of 
NHANES as well as many large epidemiology surveys (Eke et al., 2012).  Among those older 
than 30 years of age, the report shows that the disease is observed to be more prevalent 
among males than females (56% vs. 38%), and highest among current smokers (64%), 
Mexican American (67%), and individuals who have low income (65%) and low education 
(67%) (Eke et al., 2012).  In addition, the prevalence of periodontitis increased with 
increasing poverty levels and lowering education.  The prevailing disparities among socio-
economic disadvantaged groups (e.g. those with limited access to dental care) and aging 
population imply great financial burden and health care cost for prevention and treatment.  
A study examining Japanese health care enrollee aged 40-59 suggested that the hospital 
visits and health care costs were predominantly higher among those with severe 
periodontitis, and that the disease is also likely to induce a higher medical care costs for 
diabetes mellitus, digestive disease, and liver diseases (Ide et al., 2007).  Another public 
health concern due to periodontitis has been the loss of teeth.  Tooth loss in adult life may 
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be largely attributable to poor periodontal health (Petersen et al., 2005).  According to the 
NHANES report (2009-2010), edentulism is affecting more than one-third and one-eighths 
of older adults aged 65-74 living below and above federal poverty level, respectively.  The 
impaired oral function can greatly impact people’s quality of life and continues to grow as a 
public health concern and problem. 
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